Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3023709	fs-gh	ug/l (ug/l)	1442	3783	1.74%
3023709	s-gh	ug/l (ug/l)	117	214	0.00%
3023709	s-gh	— (—)	60	84	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Endocrine, nutritional and metabolic diseases

543

288

9.67

316.15

3.0

1.4

1.27

1.02

ug/l

1.09

503

278

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

763

244

32.83

307.65

3.5

1.8

1.04

1.36

ug/l

1.46

717

232

Benign neoplasm of other and unspecified endocrine glands

452

100

49.50

307.65

3.8

1.5

1.02

1.30

ug/l

0.63

437

Exclusions for E4_PCOS_BROAD

843

143

66.25

307.65

3.4

2.4

1.12

1.58

ug/l

1.94

791

136

Disorders of other endocrine glands

895

301

30.44

307.65

3.5

1.4

1.23

1.30

ug/l

0.21

837

287

Benign neoplasm of other and unspecified endocrine glands

452

53.81

307.65

3.8

1.4

1.02

1.03

ug/l

0.01

437

Used for control exclusion in common control thyroid runs

662

441

7.67

307.65

3.0

1.9

1.15

1.28

ug/l

0.51

612

425

Exclusions for E4_PCOS_CONSORTIUM

807

427

12.06

307.65

3.2

1.7

1.13

1.39

ug/l

1.27

754

410

Short stature, not elsewhere classified

144

76.41

251.82

6.4

3.2

1.99

3.10

ug/l

1.05

144

Hypothyroidism, other/unspecified

470

672

4.65

171.59

2.4

2.2

1.06

1.13

ug/l

0.22

438

641

Disorders of the thyroid gland

489

725

4.44

168.53

2.4

2.2

1.10

1.13

ug/l

0.09

455

693

Other disorders of adrenal gland

43.76

165.49

1.8

1.5

1.39

1.44

ug/l

0.03

Hypothyreosis and Thyroxine purchase for inclusion criteria

479

719

4.43

165.25

2.4

2.3

1.07

1.15

ug/l

0.27

447

687

Adrenocortical insufficiency

62.08

156.26

1.6

1.3

1.52

1.11

ug/l

0.36

Benign neoplasms

470

693

3.81

126.05

3.0

1.9

1.05

1.15

ug/l

0.39

440

641

Benign neoplasms

406

600

3.85

111.19

3.1

1.9

0.99

1.18

ug/l

0.94

378

551

Neoplasms

387

621

3.36

86.13

2.9

2.3

1.05

1.30

ug/l

1.38

360

577

Sleep disorders (combined)

401

877

3.01

80.73

2.3

2.4

1.00

1.15

ug/l

0.58

363

839

Sleep apnoea

357

770

3.16

78.66

2.4

2.3

0.96

1.11

ug/l

0.47

319

735

Sleep apnoea, including avohilmo

365

803

2.96

71.40

2.3

1.01

1.12

ug/l

0.35

330

767

Medical observation and evaluation for suspected diseases and conditions

293

467

3.23

60.72

2.0

2.5

0.87

1.20

ug/l

1.82

273

437

General symptoms and signs

426

833

2.57

59.51

2.0

2.7

1.23

1.03

ug/l

0.88

396

783

Headache

266

729

3.06

59.38

2.5

2.7

1.15

1.06

ug/l

0.21

254

691

Episodal and paroxysmal disorders

430

873

2.53

58.76

2.4

2.8

1.08

1.29

ug/l

1.13

392

839

Hypothyroidism, strict autoimmune

189

326

3.85

55.44

1.3

1.4

1.19

1.08

ug/l

0.31

173

318

First line medication for Crohn's disease

432

985

2.40

54.01

2.3

2.6

1.15

1.17

ug/l

0.06

402

930

Depression medications

150

162

4.68

49.48

2.0

2.8

1.02

0.93

ug/l

0.18

138

157

Malaise and fatigue

176

425

3.47

47.99

1.8

3.0

1.32

1.08

ug/l

0.77

166

407

Neurological diseases

340

691

2.49

44.69

2.4

3.0

1.16

1.32

ug/l

0.63

311

663

Other antidepressants

337

734

2.40

41.85

1.6

2.4

0.92

1.09

ug/l

0.71

307

691

Mood disorders, excluding more controls

330

850

2.37

41.64

1.8

2.4

0.90

1.10

ug/l

1.00

304

804

Mood [affective] disorders

357

1049

2.24

40.72

1.9

2.4

0.97

1.09

ug/l

0.53

329

989

Mood disorders

357

1050

2.24

40.49

1.9

2.4

0.97

1.09

ug/l

0.52

329

990

Other disorders of fluid, electrolyte and acid-base balance

109

253

4.18

40.41

2.3

2.4

1.03

1.12

ug/l

0.18

104

238

Depression

337

1030

2.26

39.49

1.9

2.4

1.00

1.10

ug/l

0.42

311

970

Benign neoplasm of meninges

7.08

38.55

2.6

2.2

0.72

1.12

ug/l

1.05

Any reimbursement code in KELA

250

466

2.70

38.49

2.8

2.3

1.32

1.14

ug/l

0.49

233

439

Abnormalities of breathing

340

900

2.25

38.07

2.1

2.9

1.21

1.18

ug/l

0.09

314

852

Benign neoplasm: Cerebral meninges

7.24

37.29

2.6

1.9

0.75

1.17

ug/l

1.04

Depression or dysthymia

234

492

2.67

36.71

2.0

2.7

0.83

1.08

ug/l

1.07

218

470

Recurrent or chronic depression

156

356

3.18

35.80

1.5

2.5

0.81

1.09

ug/l

0.92

145

336

Benign neoplasm of meninges

6.39

35.02

2.6

2.2

0.72

1.35

ug/l

1.80

Hypertension, essential

263

619

2.43

34.56

2.2

2.0

1.18

0.90

ug/l

1.21

245

575

Benign neoplasm: Cerebral meninges

6.56

34.06

2.6

1.9

0.75

1.28

ug/l

1.36

Anxiety disorders, excluding more controls

285

843

2.25

32.83

2.1

2.5

1.01

1.14

ug/l

0.45

270

797

Hypertensive diseases (excluding secondary)

222

512

2.53

31.83

2.4

2.7

1.31

1.04

ug/l

0.94

207

482

Metabolic disorders

306

881

2.16

31.66

3.0

2.4

1.06

1.18

ug/l

0.48

286

827

Neurological diseases, wide definition

168

283

2.99

31.04

2.5

3.4

1.10

1.44

ug/l

1.19

151

275

Selective serotonin reuptake inhibitors

312

766

2.15

30.41

1.7

2.6

1.06

1.10

ug/l

0.12

289

723

Visual disturbances and blindness

173

676

2.57

29.36

2.5

2.6

1.11

1.17

ug/l

0.18

167

639

Other special examinations and investigations of persons without complaint or reported diagnosis

226

467

2.46

29.32

2.3

2.5

1.14

1.20

ug/l

0.13

206

437

Any gastric operation

301

702

2.16

29.21

2.5

1.30

1.10

ug/l

0.85

277

661

GASTRO-related operations

301

702

2.16

29.21

2.5

1.30

1.10

ug/l

0.85

277

661

Hypertension

269

692

2.21

28.51

2.3

2.4

1.30

1.01

ug/l

1.23

250

645

Hypertensive diseases

269

694

2.20

28.34

2.3

2.4

1.30

1.01

ug/l

1.23

250

647

Fever of other and unknown origin

168

612

2.55

27.75

2.2

2.9

1.15

1.07

ug/l

0.19

156

583

Visual disturbances

162

637

2.55

27.19

2.3

2.6

1.11

1.14

ug/l

0.07

156

602

Neurotic, stress-related and somatoform disorders

298

1067

1.99

25.74

2.1

2.5

1.07

1.11

ug/l

0.13

283

997

Anxiety disorders

300

1079

1.98

25.36

2.1

2.5

1.06

1.11

ug/l

0.14

285

1009

Benzodiazepine use

303

1100

1.96

25.25

1.8

2.4

1.03

1.11

ug/l

0.30

283

1030

Codeine or tramadol medication

337

974

1.92

24.82

2.0

2.2

0.96

1.08

ug/l

0.46

317

909

Anxiety (asthma-related co-morbidities)

217

782

2.19

24.74

2.1

2.5

1.14

1.10

ug/l

0.10

207

732

Codeine

295

813

2.00

24.27

2.1

2.2

1.01

1.03

ug/l

0.04

276

760

Parasetamol

267

657

2.08

23.90

2.2

1.09

0.96

ug/l

0.45

248

611

Persons with potential health hazards related to communicable diseases

173

747

2.31

23.28

2.6

2.9

1.30

1.33

ug/l

0.07

167

705

Oedema, not elsewhere classified

266

3.27

22.96

1.7

2.7

1.01

1.05

ug/l

0.07

254

Symptoms and signs involving the circulatory and respiratory systems

338

903

1.88

22.85

2.0

2.9

1.33

1.18

ug/l

0.51

317

854

All anxiety disorders

221

849

2.10

22.75

2.1

2.4

1.14

1.08

ug/l

0.14

210

786

Any mental disorder

341

916

1.87

22.60

2.3

2.6

1.11

1.17

ug/l

0.22

318

870

Antihypertensive medication - note that there are other indications

246

650

2.08

22.41

2.2

2.9

1.42

1.14

ug/l

0.98

228

604

General examination and investigation of persons without complaint and reported diagnosis

199

467

2.27

22.40

2.2

2.5

1.25

1.20

ug/l

0.07

188

437

Intracranial trauma

177

577

2.30

22.32

2.2

3.0

1.06

1.28

ug/l

0.69

167

552

Other headache syndromes

124

476

2.61

21.97

2.2

2.4

0.75

1.29

ug/l

3.45

117

459

Persons encountering health services in other circumstances, wide

376

1094

1.79

21.90

2.3

2.6

1.34

1.13

ug/l

0.70

346

1038

Psychiatric diseases

334

903

1.86

21.74

2.3

2.6

1.12

1.18

ug/l

0.17

312

857

Persons encountering health services in other circumstances

133

531

2.51

21.70

2.0

2.9

1.04

1.13

ug/l

0.17

121

506

Mouth breathing

149

631

2.37

21.40

2.4

3.0

1.14

1.28

ug/l

0.30

135

598

Obesity related asthma

113

420

2.70

21.37

2.1

2.5

0.84

1.04

ug/l

0.69

101

396

Opioids

300

831

1.90

21.21

2.2

2.1

1.08

1.03

ug/l

0.15

279

778

Concussion

148

552

2.33

19.90

2.4

3.0

0.94

1.28

ug/l

1.39

139

528

Contact with and exposure to communicable diseases

145

628

2.31

19.68

2.4

2.9

1.33

1.32

ug/l

0.02

140

592

Other anxiety disorders

162

652

2.21

19.40

2.0

2.3

1.11

1.14

ug/l

0.04

155

603

Diseases of the ear and mastoid process

362

1060

1.73

18.94

2.1

2.6

1.06

1.16

ug/l

0.39

337

998

Other nutritional deficiencies

200

983

1.99

18.64

2.0

2.5

0.81

1.21

ug/l

2.61

181

941

Cardiovascular diseases

252

717

1.92

18.63

2.6

2.9

1.46

1.19

ug/l

0.89

228

680

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

159

723

2.16

18.35

2.1

2.4

1.12

ug/l

0.00

154

676

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

159

683

2.16

18.24

2.1

2.6

0.98

1.11

ug/l

0.45

151

648

Exposure to unspecified factor

293

1290

1.77

18.03

2.2

2.7

1.19

ug/l

0.01

273

1220

Brain meningioma, excluding all cancers (controls excluding all cancers)

6.33

18.03

2.5

1.9

0.88

1.21

ug/l

0.44

Cardiovascular diseases (excluding rheumatic etc)

252

784

1.86

17.28

2.5

2.9

1.36

1.16

ug/l

0.64

229

740

Persons encountering health services for other counselling and medical advice, not elsewhere classified

328

1091

1.72

17.22

2.4

2.6

1.35

1.14

ug/l

0.69

306

1035

Intestinal infectious diseases

281

1248

1.76

17.01

2.5

2.6

1.28

1.18

ug/l

0.31

268

1171

Other disorders of lacrimal gland

388

2.56

16.95

2.0

2.4

1.27

1.12

ug/l

0.28

363

Gastro-oesophageal reflux disease

188

847

1.97

16.73

2.2

2.6

1.25

1.05

ug/l

0.54

172

805

Asthma, excluding more controls

231

648

1.90

16.66

2.4

2.8

1.13

1.16

ug/l

0.08

215

617

Hypothyroidism, strict autoimmune, 3 medication purchases required

193

665

1.98

16.61

1.3

2.2

1.19

1.13

ug/l

0.16

177

638

Asthma

232

661

1.89

16.32

2.4

2.8

1.13

1.15

ug/l

0.06

216

630

Nausea and vomiting

367

2.56

16.15

2.7

3.5

1.88

1.35

ug/l

0.98

350

Diarrhoea and gastroenteritis of presumed infectious origin

220

1086

1.84

16.14

2.7

2.6

1.21

ug/l

0.01

210

1011

Obesity and other hyperalimentation

185

948

1.94

15.97

1.9

2.5

0.69

1.20

ug/l

4.94

167

904

Other soft tissue disorders, not elsewhere classified

279

987

1.75

15.97

2.0

2.8

1.18

1.13

ug/l

0.14

259

934

Implicit Sepsis

191

767

1.94

15.89

2.2

2.6

1.46

1.06

ug/l

1.47

179

726

Obesity

184

948

1.93

15.68

1.9

2.5

0.69

1.20

ug/l

4.88

166

904

Polycystic ovarian syndrome, consortium definition

197

612

1.95

15.65

2.2

1.29

1.23

ug/l

0.13

187

591

Behavioural syndromes associated with physiological disturbances and physical factors

120

533

2.26

15.60

2.1

2.7

1.06

1.23

ug/l

0.47

114

504

Condition for Implicit Sepsis (Organ dysfunction codes)

230

919

1.82

15.59

2.1

2.6

1.33

1.11

ug/l

0.72

215

865

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

363

2.54

15.57

1.2

2.3

1.09

1.19

ug/l

0.21

341

Asthma (mode)

224

665

1.85

15.09

2.4

2.8

1.07

1.15

ug/l

0.24

208

634

Syncope and collapse

105

393

2.37

14.98

1.7

2.7

1.05

0.97

ug/l

0.19

373

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

122

259

2.37

14.95

2.3

3.0

1.30

0.94

ug/l

0.98

108

239

Other diseases of intestines

321

1130

1.65

14.85

2.8

2.5

1.25

1.19

ug/l

0.19

298

1066

Symptoms and signs involving the nervous and musculoskeletal systems

164

838

1.96

14.77

2.0

2.8

1.48

1.18

ug/l

0.78

154

795

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

274

1162

1.69

14.45

2.2

2.7

1.04

1.23

ug/l

0.87

256

1104

Obesity due to excess calories

139

677

2.06

14.36

1.7

2.5

0.68

1.19

ug/l

4.07

126

645

Other symptoms and signs involving the nervous and musculoskeletal systems

127

598

2.13

14.34

2.1

2.8

1.43

1.16

ug/l

0.61

122

566

Disorders of lacrimal system

110

489

2.26

14.33

2.0

2.4

1.22

1.12

ug/l

0.18

105

459

Personality disorders, excluding more controls

343

2.52

14.28

1.4

2.3

1.03

1.10

ug/l

0.15

314

Pain in joint

170

575

1.96

14.18

2.2

2.7

1.02

1.07

ug/l

0.11

153

536

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

104

412

2.31

14.02

3.1

3.2

1.56

1.41

ug/l

0.31

387

Pain in throat and chest

236

819

1.76

13.96

1.9

2.7

1.09

1.08

ug/l

0.03

221

774

Gastrointestinal diseases

210

568

1.86

13.93

2.9

2.6

1.41

1.12

ug/l

0.90

192

539

Low back pain

201

850

1.82

13.92

2.1

2.3

1.10

1.12

ug/l

0.03

188

798

Type 2 diabetes, wide definition

185

639

1.89

13.83

2.3

2.2

1.21

0.96

ug/l

0.59

169

603

Tramadol

201

704

1.84

13.76

1.7

2.2

0.97

1.03

ug/l

0.17

192

661

Bipolar affective disorders

258

2.73

13.64

1.3

2.4

1.05

1.20

ug/l

0.24

238

Abnormalities of heart beat

367

2.41

13.49

1.5

2.6

1.60

1.07

ug/l

0.58

346

Diseases of the eye and adnexa

277

823

1.69

13.44

2.4

2.7

1.39

1.17

ug/l

0.77

262

765

Irregular menses

140

561

2.03

13.43

2.2

1.14

1.21

ug/l

0.14

132

543

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

261

2.69

13.35

2.0

2.1

0.96

1.01

ug/l

0.08

246

Continuous positive airway pressure

213

2.77

13.20

2.8

3.9

1.54

1.43

ug/l

0.14

207

Asthma, unspecified (mode), excluding more controls

143

562

2.00

13.15

2.2

2.8

0.95

1.21

ug/l

0.98

137

542

Nontoxic goitre/thyroid nodule

292

2.58

13.12

2.6

2.1

1.01

1.13

ug/l

0.22

277

Symptoms and signs involving cognition, perception, emotional state and behaviour

253

1055

1.68

13.08

2.1

2.4

1.31

1.09

ug/l

0.87

238

999

Asthma, unspecified (mode)

143

570

1.99

13.01

2.2

2.7

0.95

1.20

ug/l

0.96

137

550

Dyspnoea

226

1005

1.73

12.99

1.9

2.5

1.11

1.18

ug/l

0.24

208

962

Temporomandibular joint disorders

167

3.13

12.98

1.8

2.5

0.81

1.11

ug/l

0.74

158

Pain (limb, back, neck, head abdominally)

227

644

1.77

12.97

2.4

2.9

1.34

1.19

ug/l

0.37

213

606

Type 2 diabetes, definitions combined

239

834

1.71

12.75

2.3

2.2

1.11

1.03

ug/l

0.18

219

788

Poisoning by medicine

329

2.44

12.51

1.3

2.4

1.03

ug/l

0.00

301

Spondylosis

121

501

2.08

12.51

1.7

2.3

1.05

ug/l

0.01

112

477

Nerve, nerve root and plexus disorders

266

1015

1.65

12.47

2.3

2.2

0.97

1.13

ug/l

0.68

247

953

Oral corticosteroids

288

1078

1.62

12.47

1.8

2.5

1.12

1.10

ug/l

0.05

275

1007

Pain in limb

218

916

1.72

12.40

1.9

2.8

1.14

1.15

ug/l

0.05

203

872

ILD medications: prednisolone, methylprednisolone, prednisone

312

1110

1.59

12.40

2.0

2.7

1.16

1.15

ug/l

0.02

292

1047

Disorders of vestibular function (Vertigo)

105

485

2.16

12.30

1.8

2.3

1.10

1.02

ug/l

0.16

461

Dizziness and giddiness

175

781

1.82

12.26

2.2

2.4

1.28

1.08

ug/l

0.61

164

743

Poisoning by drugs, medicaments and biological substances

363

2.35

12.24

1.3

2.4

1.05

1.03

ug/l

0.03

334

Diseases of oesophagus, stomach and duodenum

288

1088

1.61

12.23

2.3

2.5

1.45

1.04

ug/l

1.63

269

1026

Diseases of inner ear

121

583

2.04

12.18

1.8

2.3

1.05

1.04

ug/l

0.03

112

554

Type 2 diabetes, strict (exclude DM1)

238

842

1.69

12.13

2.3

2.2

1.10

1.03

ug/l

0.17

218

796

Autoimmune diseases

326

1060

1.57

12.10

2.0

2.8

1.31

1.11

ug/l

0.77

297

1006

Asthma (only as main-diagnosis), excluding more controls

194

648

1.79

11.98

2.3

2.8

1.14

1.16

ug/l

0.06

178

617

Symptoms and signs involving the digestive system and abdomen

295

921

1.61

11.93

2.3

2.7

1.29

1.12

ug/l

0.52

277

866

Persons encountering health services for examination and investigation

174

467

1.87

11.92

2.4

2.5

0.97

1.20

ug/l

0.78

162

437

Asthma (only as main-diagnosis)

194

661

1.77

11.75

2.3

2.8

1.14

1.15

ug/l

0.04

178

630

Disorders of lipoprotein metabolism and other lipidaemias

179

622

1.81

11.74

2.5

2.1

0.94

1.02

ug/l

0.28

168

580

Other functional intestinal disorders

123

588

2.00

11.69

2.7

2.9

1.26

1.38

ug/l

0.25

114

566

Triptan medication for migraine, min. 3 purchases

167

726

1.82

11.61

1.8

2.4

0.91

1.21

ug/l

1.51

161

688

Dysphagia

217

2.73

11.60

2.4

2.6

1.10

1.05

ug/l

0.07

205

Benign neoplasm of colon, rectum, anus and anal canal

123

560

1.99

11.43

4.7

1.9

1.28

1.07

ug/l

0.28

118

532

Soft tissue disorders

308

1021

1.57

11.40

2.3

2.8

1.18

1.15

ug/l

0.07

287

966

140

739

1.88

11.32

2.7

2.8

1.15

1.29

ug/l

0.34

130

702

Symptoms and signs involving the skin and subcutaneous tissue

177

1007

1.75

11.31

2.6

2.5

1.40

1.14

ug/l

0.60

167

961

Coxibs

158

2.57

11.29

1.6

2.2

0.72

0.94

ug/l

0.68

151

Asthma-related infections

162

891

1.79

11.16

2.5

2.7

1.16

1.25

ug/l

0.21

151

846

Asthma, hospital admission 2, infections

162

891

1.79

11.16

2.5

2.7

1.16

1.25

ug/l

0.21

151

846

Complications of procedures, not elsewhere classified

200

1022

1.69

11.07

2.5

2.3

1.13

1.15

ug/l

0.04

191

966

Type 2 diabetes, definitions combined, including avohilmo

237

852

1.65

11.06

2.3

2.2

0.98

1.01

ug/l

0.09

217

805

ILD medications

323

1156

1.54

11.04

2.0

2.7

1.14

1.18

ug/l

0.10

300

1093

Benign neoplasm of colon, rectum, anus and anal canal

122

437

2.00

11.03

4.7

1.8

1.29

1.04

ug/l

0.34

117

407

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

264

1128

1.59

11.03

2.6

2.7

1.59

1.13

ug/l

2.54

254

1074

Genitourinary diseases

214

628

1.71

11.02

2.6

3.1

1.17

1.15

ug/l

0.07

198

587

Other dorsopathies, not elsewhere classified

276

914

1.60

11.01

1.9

2.4

0.98

1.12

ug/l

0.64

257

859

Acetic acid derivatives and related substances

154

2.54

10.89

1.7

2.1

1.31

0.91

ug/l

0.77

147

Bacterial Sepsis

418

2.11

10.85

2.1

2.6

1.61

0.97

ug/l

1.62

398

Abdominal and pelvic pain

288

920

1.58

10.81

2.2

2.7

1.23

1.12

ug/l

0.31

269

865

Spondylopathies

186

647

1.75

10.81

1.9

2.3

1.03

1.08

ug/l

0.08

171

613

Symptoms and signs involving the urinary system

180

802

1.74

10.74

2.3

2.5

1.11

1.10

ug/l

0.02

172

758

Disorders of eyelid, lacrimal system and orbit

200

932

1.69

10.73

2.1

2.5

1.25

1.18

ug/l

0.18

193

887

Triptan medication for migraine, single purchase ok

222

912

1.65

10.70

2.1

2.3

1.04

1.13

ug/l

0.31

203

859

Migraine, single triptan purchase ok & required. ICD-code if available is included

222

912

1.65

10.70

2.1

2.3

1.04

1.13

ug/l

0.31

203

859

Type 2 diabetes

248

913

1.62

10.69

2.3

2.2

1.11

1.03

ug/l

0.22

225

861

Obesity, other/unspecified

460

2.09

10.51

2.0

2.3

0.69

1.16

ug/l

2.64

435

Other symptoms and signs involving cognitive functions and awareness

405

2.14

10.49

2.2

2.5

1.13

1.01

ug/l

0.29

385

Other neurological diseases

155

696

1.79

10.39

2.4

1.21

1.09

ug/l

0.26

144

665

Dorsalgia

264

903

1.59

10.36

1.8

2.4

0.96

1.13

ug/l

0.80

246

848

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

112

567

1.96

10.22

3.5

3.0

1.72

1.40

ug/l

0.69

104

543

Nontoxic multinodular goitre

123

3.18

10.10

2.6

1.7

1.27

1.13

ug/l

0.13

117

Diseases of the musculoskeletal system and connective tissue

199

589

1.70

10.02

2.5

3.0

1.22

1.27

ug/l

0.13

184

558

Diaphragmatic hernia

364

2.20

10.00

2.0

2.3

0.79

1.00

ug/l

0.91

344

ILD differential diagnosis

219

665

1.65

9.96

1.9

2.8

1.27

1.15

ug/l

0.30

202

634

COPD differential diagnosis

219

666

1.65

9.90

1.9

2.8

1.27

1.15

ug/l

0.30

202

635

Acute upper respiratory infections of multiple and unspecified sites

208

959

1.63

9.73

2.2

2.7

1.30

1.13

ug/l

0.46

192

915

Dorsopathies

284

950

1.53

9.42

2.1

2.6

0.98

1.16

ug/l

0.88

264

895

Examination and observation for other reasons

139

465

1.82

9.30

2.9

2.5

1.34

1.20

ug/l

0.33

129

435

Excluding asthma or asthma-COPD overlap

217

670

1.62

9.29

1.9

2.8

1.28

1.15

ug/l

0.32

202

637

Specific personality disorders

363

2.16

9.27

1.3

2.3

1.02

1.07

ug/l

0.09

335

Injuries to the head

293

1278

1.49

9.25

2.3

2.6

1.18

1.17

ug/l

0.03

279

1203

Complications of surgical and medical care, not elsewhere classified

236

1089

1.56

9.12

2.4

2.3

1.08

1.14

ug/l

0.16

224

1029

Pain, not elsewhere classified

283

2.30

9.07

2.2

3.0

0.88

1.16

ug/l

0.98

268

Intracranial injury

150

844

1.72

9.05

2.2

2.8

1.02

1.17

ug/l

0.44

142

791

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

460

2.01

9.05

1.2

2.3

1.09

1.12

ug/l

0.04

430

Asthma (diagnoses ohter than nonallergic)

227

1250

1.56

9.01

2.4

2.6

1.09

1.23

ug/l

0.48

212

1189

Autoimmune diseases excluding thyroid diseases

284

1048

1.51

9.01

2.4

2.8

1.31

1.09

ug/l

0.78

267

994

Acute upper respiratory infections

263

1084

1.52

8.98

2.1

2.6

1.23

1.14

ug/l

0.25

241

1039

Autoimmune diseases related-to ILD

216

1214

1.57

8.91

2.2

2.4

1.19

1.08

ug/l

0.32

196

1145

Personality disorders

423

2.04

8.86

1.4

2.3

1.03

1.08

ug/l

0.11

392

Dermatitis and eczema

286

1262

1.49

8.85

2.1

2.6

1.18

ug/l

0.00

264

1194

Inflammatory bowel disease treatment related agents

307

1185

1.47

8.82

2.1

2.6

1.25

1.13

ug/l

0.45

291

1113

Lack of expected normal physiological development

3.22

8.77

4.9

6.0

2.66

1.73

ug/l

1.46

Disturbances of skin sensation

372

2.10

8.73

2.8

2.3

1.18

1.06

ug/l

0.26

348

Spinal stenosis

392

1.96

8.71

1.9

2.3

1.30

1.02

ug/l

0.38

375

Cerebrovascular diseases (FINNGEN)

232

2.23

8.68

2.6

2.2

1.20

0.90

ug/l

0.56

223

Diseases of the respiratory system

180

542

1.67

8.54

2.2

2.9

1.25

1.20

ug/l

0.09

164

523

Pain and other conditions associated with female genital organs and menstrual cycle

266

2.28

8.53

2.2

2.1

1.38

1.17

ug/l

0.28

256

Other pulmonary diagnosis

213

670

1.59

8.52

1.9

2.8

1.28

1.15

ug/l

0.32

198

637

Asthma, hospital admissions , main diagnosis only

216

1255

1.54

8.39

2.5

2.6

1.13

1.23

ug/l

0.27

200

1192

Dermatitis

145

858

1.69

8.34

1.8

2.6

1.29

1.21

ug/l

0.17

132

820

COPD/asthma/ILD related infections

276

926

1.49

8.30

2.1

2.7

1.23

1.18

ug/l

0.12

251

888

COPD/asthma related infections

276

926

1.49

8.30

2.1

2.7

1.23

1.18

ug/l

0.12

251

888

Diverticular disease of intestine

134

506

1.76

8.27

3.7

1.8

1.11

0.96

ug/l

0.37

126

482

Factors influencing health status and contact with health services

203

2.10

8.19

2.5

2.6

1.53

1.16

ug/l

0.54

190

Lower back pain or/and sciatica

249

1152

1.50

8.18

2.0

2.2

1.03

1.08

ug/l

0.17

235

1078

Diabetes mellitus

270

1090

1.48

8.06

2.4

2.5

1.11

ug/l

0.02

246

1029

Certain infectious and parasitic diseases

279

945

1.48

8.03

2.3

2.7

1.35

1.20

ug/l

0.48

259

894

Pure hypercholesterolaemia

140

546

1.72

8.03

2.5

2.1

0.96

1.04

ug/l

0.23

133

512

Other and unspecified iron deficiency

371

2.05

8.02

2.7

2.6

1.41

1.27

ug/l

0.27

355

Diabetes, varying definitions

268

1084

1.48

7.98

2.4

2.5

1.10

1.12

ug/l

0.03

244

1023

Haemorrhage from respiratory passages

307

2.12

7.94

2.1

3.1

0.85

1.07

ug/l

0.80

292

Influenza and pneumonia

281

1275

1.45

7.74

2.2

2.7

1.12

1.22

ug/l

0.37

263

1203

Other diseases of upper respiratory tract

283

1011

1.46

7.73

2.4

2.7

1.30

1.24

ug/l

0.11

266

953

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

247

2.28

7.66

1.2

2.3

1.05

1.01

ug/l

0.09

225

Nutritional anaemias

101

537

1.83

7.65

2.4

2.7

1.23

1.20

ug/l

0.07

513

Other specific joint derangements/joint disorders

199

861

1.55

7.60

2.1

2.3

1.05

1.06

ug/l

0.01

181

811

Unspecified mental disorder

112

634

1.77

7.59

1.2

2.2

1.12

0.99

ug/l

0.26

103

579

Other diseases of hard tissues of teeth

175

822

1.59

7.56

2.7

2.6

1.32

1.19

ug/l

0.36

168

776

Falls/tendency to fall

312

1094

1.43

7.55

2.3

2.7

1.26

1.20

ug/l

0.19

285

1038

Benign neoplasm: Ascending colon

103

3.02

7.45

6.6

2.0

1.27

1.03

ug/l

0.33

Presence of other functional implants

104

403

1.83

7.42

1.7

2.6

1.22

0.90

ug/l

0.73

388

Other/unspecified dorsalgia

443

1.91

7.39

1.3

2.5

0.87

1.20

ug/l

1.01

421

Fall on same level

312

1231

1.42

7.38

2.2

2.7

1.14

1.18

ug/l

0.12

292

1164

Other disorders of ear

213

936

1.52

7.38

2.1

2.6

0.99

1.17

ug/l

0.84

202

886

Iron deficiency anaemia

476

1.88

7.37

2.5

2.7

1.33

1.23

ug/l

0.20

454

Vasomotor and allergic rhinitis

117

668

1.73

7.32

2.3

2.9

0.93

1.38

ug/l

1.34

106

629

Disorders of adult personality and behaviour

461

1.89

7.32

1.4

2.3

1.02

1.10

ug/l

0.17

428

Acute tubulo-interstitial nephritis

139

745

1.66

7.32

2.1

2.6

1.26

1.20

ug/l

0.11

130

713

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

222

926

1.50

7.29

1.9

2.7

1.05

1.18

ug/l

0.48

210

888

222

926

1.50

7.29

1.9

2.7

1.05

1.18

ug/l

0.48

210

888

Sensorineural hearing loss

151

647

1.64

7.26

2.0

2.4

1.04

1.08

ug/l

0.09

143

614

Other and unspecified effects of external causes

463

1.88

7.23

2.1

2.8

1.06

1.31

ug/l

0.57

434

Other and unspecified mood [affective] disorders

3.07

7.15

1.8

2.6

1.00

1.21

ug/l

0.31

Systemic connective tissue disorders

395

1.95

7.14

1.6

2.5

1.41

1.16

ug/l

0.48

374

Complications of medical and surgical care

158

947

1.59

7.06

2.5

2.3

1.05

1.17

ug/l

0.32

149

904

Conductive and sensorineural hearing loss

162

705

1.59

7.01

2.1

2.5

1.03

1.08

ug/l

0.13

152

670

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

111

398

1.77

7.00

2.0

2.2

1.82

0.97

ug/l

1.36

100

379

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

129

775

1.66

6.99

2.8

2.3

1.10

1.22

ug/l

0.26

122

736

Renal tubulo-interstitial diseases

201

1022

1.51

6.98

2.1

2.6

1.49

1.21

ug/l

0.89

190

977

Voice disturbances

310

2.07

6.97

1.9

2.4

1.29

1.06

ug/l

0.29

293

Use of hypnotics and sedatives

259

1036

1.45

6.94

1.8

2.5

1.01

1.12

ug/l

0.40

242

973

Other arrhythmias

150

716

1.61

6.85

1.7

2.5

1.46

1.06

ug/l

0.71

140

681

Carpal tunnel syndrome

126

684

1.67

6.81

2.7

2.2

1.05

1.18

ug/l

0.32

119

652

Suicide or other Intentional self-harm

361

1.97

6.78

1.2

2.2

1.13

1.05

ug/l

0.15

333

Cystitis

201

815

1.51

6.72

1.9

2.7

1.15

1.25

ug/l

0.28

190

784

Deforming dorsopathies

349

1.98

6.69

2.5

2.8

0.78

1.21

ug/l

1.75

330

Asthma, including avohilmo

303

1263

1.40

6.66

2.3

2.6

1.15

1.19

ug/l

0.11

279

1197

Symptoms and signs involving speech and voice

371

1.95

6.63

1.9

2.3

1.55

1.02

ug/l

0.83

351

Bronchitis

259

1192

1.43

6.60

2.1

2.5

1.22

1.12

ug/l

0.29

237

1134

Chronic sinusitis

100

572

1.75

6.60

2.0

2.4

0.84

1.18

ug/l

1.49

540

Other and unspecified dermatitis

118

709

1.67

6.53

1.8

2.6

1.31

1.18

ug/l

0.29

109

677

Diseases of the skin and subcutaneous tissue

272

959

1.42

6.52

2.0

2.7

1.31

1.19

ug/l

0.34

247

908

Mental and behavioural disorders due to opioids

3.67

6.48

1.1

2.5

1.14

1.16

ug/l

0.01

Benign neoplasm: Ascending colon

112

2.78

6.46

6.6

1.8

1.27

1.18

ug/l

0.10

103

Abnormal findings on examination of blood, without diagnosis

504

1.77

6.42

2.0

2.5

1.07

ug/l

0.00

477

All pneumoniae

261

1275

1.41

6.42

2.2

2.7

1.16

1.22

ug/l

0.16

246

1201

Polyuria

196

2.30

6.40

2.7

2.3

1.12

1.05

ug/l

0.07

183

Other (not insulin) diabetes medications

216

886

1.47

6.39

2.3

2.2

1.14

1.01

ug/l

0.31

195

837

Emotionally unstable personality disorder

190

2.33

6.39

1.4

2.2

1.17

1.01

ug/l

0.20

173

Noninfective enteritis and colitis

124

760

1.63

6.34

2.4

2.9

1.35

1.19

ug/l

0.39

117

712

Osteopathies and chondropathies

118

677

1.66

6.32

2.3

2.5

1.27

1.11

ug/l

0.35

109

640

Dental pulpitis 1

275

1014

1.41

6.32

2.4

2.6

1.18

ug/l

0.00

256

964

Cervical disc disorders

392

1.89

6.29

1.9

2.4

0.83

1.02

ug/l

0.52

373

Kela-code for severe mental illness

559

1.74

6.27

1.2

2.3

1.08

0.96

ug/l

0.21

510

Constipation

199

964

1.48

6.27

2.3

2.8

1.23

1.26

ug/l

0.07

182

929

Pneumonia, organism unspecified

227

1142

1.44

6.21

2.1

2.7

1.28

1.22

ug/l

0.18

213

1074

Urticaria and erythema

102

599

1.71

6.17

2.3

2.9

1.12

1.37

ug/l

0.78

568

Dental pulpitis 4

274

1014

1.40

6.17

2.3

2.6

1.18

ug/l

0.00

255

964

Substance abuse, excluding more controls

120

641

1.64

6.15

1.6

2.3

1.14

0.99

ug/l

0.35

108

596

External causes of morbidity and mortality

193

644

1.50

6.12

2.3

2.9

1.29

1.34

ug/l

0.12

176

614

Other joint disorders

242

901

1.43

6.10

2.4

1.14

1.08

ug/l

0.18

223

850

Any operation in hilmo

8.95

6.07

2.0

3.9

0.98

1.75

ug/l

—

Pneumonias (Asthma/COPD co-morbidities)

257

1271

1.40

6.05

2.2

2.7

1.19

1.21

ug/l

0.06

242

1197

Endometriosis

275

1.84

6.05

1.8

2.0

1.43

1.19

ug/l

0.39

265

Other external causes of accidental injury

230

797

1.45

6.05

2.2

2.8

1.23

1.26

ug/l

0.06

213

759

Diseases of male genital organs

151

483

1.58

6.04

2.3

3.0

1.07

ug/l

0.01

135

445

Chronic rhinitis, nasopharyngitis and pharyngitis

448

1.81

6.04

2.0

2.8

0.99

1.23

ug/l

0.56

425

Arthrosis

161

571

1.55

6.03

2.7

2.0

1.09

0.91

ug/l

0.52

148

538

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

117

718

1.63

5.99

2.8

2.3

1.13

1.18

ug/l

0.09

110

679

Autoimmune diseases excluding thyroid diseases, strict definition

214

820

1.46

5.94

2.2

2.7

1.36

1.14

ug/l

0.68

199

778

Acute sinusitis

133

786

1.58

5.92

1.7

2.5

0.89

1.08

ug/l

0.69

120

746

Other bacterial diseases

221

1070

1.43

5.82

2.1

2.7

1.31

1.13

ug/l

0.58

210

1002

Diseases of pulp and periapical tissues, including avohilmo

271

1014

1.39

5.77

2.4

2.6

1.19

1.18

ug/l

0.03

252

964

Chronic lower respiratory diseases

312

1247

1.35

5.73

2.3

2.6

1.18

ug/l

0.00

290

1180

Accidents

227

797

1.43

5.61

2.2

2.8

1.27

1.26

ug/l

0.04

208

759

Lumbar disc prolapse

138

707

1.55

5.59

2.0

2.3

0.67

1.11

ug/l

4.14

130

668

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

248

1256

1.39

5.58

2.2

2.7

1.21

1.20

ug/l

0.02

233

1184

Soft tissue disorders related to use, overuse and pressure

269

2.01

5.54

1.3

2.4

1.49

0.93

ug/l

0.97

257

269

1031

1.38

5.52

2.2

2.6

1.24

1.14

ug/l

0.30

245

988

Dental operations

149

496

1.54

5.42

2.5

2.4

1.21

1.20

ug/l

0.01

140

471

Other arthrosis

102

439

1.66

5.40

2.3

2.0

1.03

0.88

ug/l

0.53

415

Other diseases of urinary system

238

960

1.40

5.33

2.0

2.7

1.09

1.24

ug/l

0.60

226

917

Congenital malformations of the nervous system

3.45

5.33

6.1

4.8

1.94

1.87

ug/l

0.03

Deposits [accretions] on teeth

162

2.28

5.28

4.4

4.7

2.40

1.72

ug/l

0.78

155

Disorders of synovium and tendon

117

667

1.58

5.26

2.0

2.6

1.46

1.14

ug/l

0.42

110

638

Shoulder lesions

159

651

1.50

5.24

2.2

2.4

0.91

0.98

ug/l

0.20

146

618

Noninflammatory disorders of female genital tract

105

317

1.67

5.22

1.9

2.1

1.03

1.21

ug/l

0.54

305

Cough

536

1.67

5.22

1.8

3.2

1.17

1.27

ug/l

0.25

513

Hyperplasia of prostate

210

1.88

5.21

1.7

2.5

0.84

0.87

ug/l

0.03

199

Other disorders of skin and subcutaneous tissue

133

797

1.53

5.20

1.7

2.5

1.60

1.09

ug/l

1.51

127

757

Other enthesopathies

339

1.86

5.18

1.6

2.4

0.74

0.94

ug/l

0.62

325

Sciatica+with lumbago

103

604

1.62

5.17

1.7

2.3

0.79

1.18

ug/l

2.38

574

Cardiac arrhythmias

159

707

1.49

5.17

1.8

2.7

1.66

1.08

ug/l

1.15

148

673

Hernia

216

1046

1.40

5.15

2.4

1.19

1.15

ug/l

0.10

198

982

Persons encountering health services for specific procedures and health care

274

1257

1.35

5.14

2.5

2.6

1.27

1.15

ug/l

0.29

265

1178

Internal derangement of knee

494

1.70

5.09

1.4

2.1

0.97

0.96

ug/l

0.03

465

Other disorders of urethra and urinary system

145

725

1.50

5.02

2.0

2.6

1.05

1.19

ug/l

0.50

139

699

Dental pulpitis 1, only avohilmo

268

1032

1.36

5.02

2.3

2.5

1.15

1.14

ug/l

0.04

250

981

Heart failure, not strict

145

667

1.50

4.96

1.9

2.6

1.32

1.05

ug/l

0.82

140

632

Dental pulpitis 4, only avohilmo

267

1031

1.35

4.92

2.3

2.5

1.17

1.15

ug/l

0.06

249

980

Crossbite

197

2.09

4.90

6.1

4.8

1.22

1.73

ug/l

1.15

191

Malignant neoplasm of eye, brain and central nervous system

3.36

4.89

3.4

1.21

1.83

ug/l

0.49

Meniscus derangement

115

501

1.57

4.86

2.2

2.0

0.99

0.86

ug/l

0.41

108

471

Diseases of oral cavity, salivary glands and jaws

229

850

1.38

4.82

2.8

2.6

1.31

1.24

ug/l

0.19

217

804

Diseases of middle ear and mastoid

158

891

1.45

4.78

2.1

2.7

1.24

1.21

ug/l

0.05

146

829

Arthropathies

247

924

1.36

4.73

2.6

2.5

1.17

1.11

ug/l

0.20

227

873

Delayed milestone in childhood

131

2.34

4.71

5.5

5.9

2.58

2.10

ug/l

0.53

131

Any event in cancer register

221

952

1.38

4.70

2.3

2.4

1.23

1.14

ug/l

0.25

209

900

Biguanides

199

876

1.40

4.70

2.2

1.14

1.03

ug/l

0.25

183

828

Artrosis, including avohilmo

190

739

1.41

4.59

2.4

2.1

1.06

0.98

ug/l

0.21

172

695

Infections of the skin and subcutaneous tissue

146

1002

1.45

4.53

2.3

2.7

1.16

1.17

ug/l

0.03

135

937

Excessive, frequent and irregular menstruation

307

1.65

4.51

1.9

2.1

1.09

1.21

ug/l

0.21

296

Bleeding

168

858

1.43

4.51

2.0

2.6

1.31

1.10

ug/l

0.58

160

812

Obsessive-compulsive disorder

2.66

4.48

1.7

2.8

1.42

1.06

ug/l

0.28

Other intervertebral disc disorders

175

755

1.42

4.47

2.0

2.3

0.76

1.13

ug/l

2.91

165

709

Disorders of skin appendages

115

760

1.51

4.40

2.0

2.5

1.17

1.16

ug/l

0.03

109

714

Other disorders of gingiva or/and edentulous alveolar ridge

2.84

4.39

4.7

3.8

2.23

1.70

ug/l

0.34

Slow fetal growth and fetal malnutrition

3.34

4.37

5.3

6.5

2.13

2.54

ug/l

0.26

Hypertensive heart and/or renal disease

134

2.14

4.34

3.7

1.6

1.16

0.74

ug/l

1.08

126

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

2.66

4.32

3.6

3.1

1.47

1.73

ug/l

0.16

Undescended testicle

3.12

4.27

6.6

5.9

2.01

2.04

ug/l

0.02

Adverse effects, not elsewhere classified

318

1.80

4.26

2.0

2.9

0.95

1.40

ug/l

1.20

299

Dental operations, only avohilmo

157

558

1.44

4.24

2.7

2.5

1.13

1.27

ug/l

0.42

147

530

Erysipelas

568

1.56

4.21

1.8

2.3

1.15

0.92

ug/l

0.50

531

Injury, poisoning and certain other consequences of external causes

157

547

1.44

4.18

2.2

3.0

1.31

1.40

ug/l

0.20

142

523

Other disorders of veins

439

1.66

4.18

1.8

2.1

0.83

0.99

ug/l

0.58

415

Finngen Rheumatological endpoints

241

1032

1.33

4.16

2.1

2.4

1.08

1.12

ug/l

0.11

218

974

Propionic acid derivatives

221

1.71

4.14

2.4

3.2

1.02

1.03

ug/l

0.01

214

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

3.00

4.12

4.4

3.2

1.17

1.61

ug/l

0.29

Paralytic strabismus

2.81

4.12

2.6

2.3

0.94

1.30

ug/l

0.38

Cholelithiasis

158

783

1.42

4.11

2.3

2.2

1.10

1.12

ug/l

0.06

147

746

Fall on and from stairs and steps

307

1.80

4.11

1.9

2.5

1.02

1.12

ug/l

0.20

288

Personal history of other diseases and conditions

242

1.90

4.09

5.0

3.8

2.16

1.42

ug/l

1.23

230

Chronic periapical parodontitis

222

1.94

4.09

3.0

2.2

0.68

1.02

ug/l

1.50

207

Disorders of gallbladder, biliary tract and pancreas

200

947

1.36

4.08

2.3

2.4

1.07

1.11

ug/l

0.11

188

896

Family history of other specific disorders

8.11

4.07

1.4

4.7

1.07

1.97

ug/l

—

Bacterial infection, other or unspecified

552

1.55

4.07

2.1

2.7

1.14

1.09

ug/l

0.09

524

Motor disorders, excluding more controls

2.74

4.04

5.7

6.0

2.60

1.93

ug/l

0.49

Allergic rhinitis

617

1.54

4.04

2.5

3.1

0.95

1.40

ug/l

1.09

588

Cholecystectomy

128

778

1.46

4.01

2.3

2.2

1.02

1.12

ug/l

0.22

120

742

Open wound of head

115

769

1.47

3.92

3.0

2.8

1.18

1.10

ug/l

0.17

110

713

Injuries to the knee and lower leg

277

1226

1.29

3.91

2.2

2.5

0.96

1.16

ug/l

0.90

258

1157

Transport accidents

108

640

1.50

3.91

1.7

2.6

1.11

1.14

ug/l

0.05

101

604

Dislocation, sprain and strain of joints and ligaments of knee

145

955

1.41

3.89

2.2

0.91

1.10

ug/l

0.56

135

891

Haemorrhoids and perianal venous thrombosis

248

1.86

3.85

2.0

1.8

0.73

0.97

ug/l

0.46

235

Acute suppurative otitis media

529

1.56

3.83

2.2

3.1

1.08

1.29

ug/l

0.62

493

Hyperprolactinaemia, drug-induced

12.31

3.78

1.5

2.2

1.36

1.86

ug/l

—

Other acute lower respiratory infections

123

813

1.45

3.78

2.5

2.8

1.18

1.19

ug/l

0.02

111

767

Cholelithiasis, broad definition with cholecystitis

162

801

1.39

3.77

2.3

2.2

1.05

1.11

ug/l

0.12

150

764

Suppurative and unspecified otitis media

109

653

1.48

3.76

2.1

2.9

1.14

1.25

ug/l

0.21

604

Mental and behavioural disorders due to psychoactive substance use

129

852

1.43

3.74

1.5

2.2

1.12

0.94

ug/l

0.50

117

782

Supplementary factors related to causes of morbidity and mortality classified elsewhere

446

1.62

3.73

1.7

2.7

1.62

1.16

ug/l

0.84

417

Anti-inflammatory and antirheumatic products, non-steroids

221

1.66

3.70

2.5

3.2

0.98

1.03

ug/l

0.09

214

Gingivitis and periodontal diseases

210

812

1.34

3.68

2.7

2.5

1.28

1.15

ug/l

0.36

197

766

Diabetes medication

240

1119

1.30

3.67

2.3

2.5

1.35

1.09

ug/l

0.72

218

1056

Type of accident

403

1.64

3.63

1.8

2.7

1.59

1.14

ug/l

0.76

377

Rotator cuff syndrome

110

555

1.47

3.62

2.1

2.3

0.92

0.97

ug/l

0.13

102

530

Hypoglycaemia, other or unspecified

104

2.32

3.59

3.3

3.5

2.68

1.63

ug/l

0.89

Sequelae of injuries of head

2.76

3.59

1.6

2.4

0.86

1.12

ug/l

0.33

Gonarthrosis [arthrosis of knee](FG)

141

588

1.41

3.57

2.2

2.1

1.08

1.00

ug/l

0.12

130

559

Portal vein thrombosis

7.86

3.57

2.3

4.1

3.08

1.38

ug/l

—

Disorders of orbit

3.19

3.49

2.8

2.4

0.99

1.13

ug/l

0.13

Abnormal involuntary movements

158

2.03

3.49

2.4

2.7

1.48

1.07

ug/l

0.35

145

Hypertensive Heart Disease

122

2.08

3.48

4.2

1.7

1.04

0.74

ug/l

0.75

114

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

211

980

1.32

3.46

2.2

2.6

1.25

1.12

ug/l

0.28

194

923

Polyarthropathies

146

701

1.39

3.45

2.5

2.4

1.27

1.07

ug/l

0.48

137

664

Other viral diseases

582

1.51

3.42

2.4

3.1

1.23

1.36

ug/l

0.25

550

Urticaria

504

1.55

3.42

2.6

2.9

1.23

1.40

ug/l

0.37

476

Malignant neoplasm of adrenal gland, excluding all cancers (controls excluding all cancers)

7.16

3.38

2.1

5.3

1.88

1.84

ug/l

—

136

2.10

3.37

5.5

5.6

2.47

2.29

ug/l

0.18

136

Anomalies of dental arch relationship, including avohilmo

369

1.61

3.34

5.7

3.2

1.35

1.45

ug/l

0.21

347

Congenital malformations, deformations and chromosomal abnormalities

150

1059

1.36

3.28

2.4

2.6

1.36

1.16

ug/l

0.65

144

988

Other and unspecified tonsillitis

101

588

1.46

3.27

2.8

2.9

1.24

1.10

ug/l

0.27

553

Cluster headache, strict, including avohilmo

2.59

3.21

2.0

2.5

0.44

1.03

ug/l

2.12

Dental caries 1 and operation codes

191

741

1.32

3.19

2.6

2.7

1.15

1.25

ug/l

0.32

181

704

Pain associated with micturition

144

2.02

3.15

1.8

3.0

1.05

1.28

ug/l

0.33

134

Dental caries 3 and operation codes

201

788

1.31

3.13

2.7

2.8

1.09

1.28

ug/l

0.81

189

748

151

1.99

3.13

5.5

5.4

2.36

2.18

ug/l

0.19

151

Cluster headache, wide,, including avohilmo

2.55

3.12

2.0

2.5

0.44

1.01

ug/l

2.06

Oxicams

118

1.88

3.12

2.2

0.75

0.96

ug/l

0.40

112

Viral infections characterized by skin and mucous membrane lesions

682

1.44

3.03

2.7

2.8

1.08

1.25

ug/l

0.42

641

Keratitis

487

1.52

3.03

1.9

2.5

0.97

1.07

ug/l

0.18

455

Other disorders of glucose regulation and pancreatic internal secretion

126

2.07

3.02

3.5

3.4

2.67

1.59

ug/l

1.04

116

Turner's syndrome

10.48

3.01

7.0

4.2

2.93

2.23

ug/l

—

Chronic diseases of tonsils and adenoids

193

939

1.30

3.01

2.5

2.8

1.30

1.27

ug/l

0.07

181

881

Other and unspecified disorders of autonomic nervous system

10.31

3.00

1.0

2.2

1.71

1.17

ug/l

—

Malignant neoplasm of other endocrine glands and related structures, excluding all cancers (controls excluding all cancers)

10.26

3.00

10.0

4.0

4.00

1.61

ug/l

—

Exposure to other specified factors

172

1231

1.31

2.99

2.3

2.5

0.93

1.16

ug/l

0.97

161

1155

Neuroendocrine tumor and carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

10.21

2.99

4.6

2.2

0.57

1.15

ug/l

—

Injuries to the wrist and hand

227

1296

1.27

2.99

2.0

2.6

1.07

1.14

ug/l

0.22

209

1226

Postviral fatigue syndrome

10.14

2.99

2.0

2.8

1.47

1.96

ug/l

—

Ovarian cyst

291

1.53

2.98

1.5

2.0

1.17

ug/l

0.01

280

Other specified congenital malformation syndromes affecting multiple systems

2.67

2.98

3.9

5.6

2.19

2.12

ug/l

0.03

Single delivery by forceps and vacuum extractor

191

0.38

2.95

1.2

1.8

2.34

0.90

ug/l

1.26

178

Acute bronchitis

568

1.47

2.93

2.1

3.0

1.17

1.27

ug/l

0.22

541

Other or unspecified ileus, impaction or obstruction

148

1.96

2.93

2.7

2.0

1.25

1.16

ug/l

0.11

143

Other congenital malformations

206

1.80

2.89

2.8

4.0

1.81

1.57

ug/l

0.28

197

Enlarged lymph nodes

170

1.89

2.89

2.3

3.3

1.18

1.19

ug/l

0.01

159

Nonsuppurative otitis media

405

1.52

2.83

3.0

1.99

1.38

ug/l

0.92

380

Injuries to the abdomen, lower back, lumbar spine and pelvis

500

1.49

2.82

1.7

2.4

1.37

1.09

ug/l

0.71

472

Open bite

123

2.04

2.81

5.4

4.0

1.64

1.55

ug/l

0.08

118

Autonomic disorders

4.48

2.80

1.1

2.8

1.46

1.52

ug/l

—

Gonarthrosis

116

478

1.39

2.79

2.2

1.9

1.18

0.93

ug/l

0.40

105

452

Specific developmental disorder of motor function

2.25

2.77

5.7

6.0

2.60

1.87

ug/l

0.58

Substance abuse

120

841

1.36

2.77

1.6

2.2

1.14

0.93

ug/l

0.57

108

772

Neuroendocrine tumor and carcinoma of pancreas

8.51

2.76

4.6

2.0

0.57

1.61

ug/l

—

Atrial fibrillation and flutter with reimbursement

145

1.77

2.76

1.9

2.0

1.52

0.68

ug/l

1.43

139

Certain conditions originating in the perinatal period

218

1.71

2.74

4.9

4.2

1.67

1.59

ug/l

0.10

212

Coxarthrosis

356

1.49

2.74

3.3

2.0

1.23

0.91

ug/l

0.61

341

Mental disorders, not otherwise specified

118

2.04

2.71

1.5

2.3

1.14

1.03

ug/l

0.09

109

Rosacea

125

2.01

2.70

1.7

2.0

1.09

1.19

ug/l

0.07

117

Diabetes, insulin treatment (Kela reimbursement)

216

1048

1.26

2.67

2.2

2.6

1.24

1.10

ug/l

0.31

199

984

Extracorporeal dialysis

2.34

2.65

2.6

3.0

3.01

1.51

ug/l

0.90

Other disorders of kidney and ureter

147

1.91

2.64

2.0

2.6

1.54

1.37

ug/l

0.17

136

LeFortI or BSSRO operation

2.47

2.62

3.5

2.3

0.73

1.04

ug/l

0.61

Covid-19 confirmed case

375

1.55

2.62

1.8

2.5

1.26

1.19

ug/l

0.09

352

Allergic asthma (mode)

353

1.56

2.60

2.6

3.0

1.41

1.19

ug/l

0.22

337

Allergic asthma (mode), excluding more controls

353

1.56

2.60

2.6

3.0

1.41

1.19

ug/l

0.23

337

Venous thromboembolism

562

1.43

2.59

1.5

2.3

0.94

1.04

ug/l

0.26

532

Pollen allergy

444

1.50

2.58

2.6

3.4

1.02

1.52

ug/l

0.84

421

Other osteochondrodysplasias

4.08

2.58

3.6

5.5

0.37

2.47

ug/l

—

Nephropathy related operations

170

1.83

2.58

2.6

3.3

2.82

1.39

ug/l

1.62

159

Appendectomy

141

1034

1.31

2.57

1.8

2.3

1.24

1.06

ug/l

0.38

130

966

Dental pulpitis 2, only avohilmo

158

617

1.31

2.56

2.6

2.8

1.32

1.28

ug/l

0.09

150

585

Benign intracranial hypertension

5.53

2.55

1.5

2.3

0.97

1.66

ug/l

—

Dental pulpitis 2

155

605

1.31

2.54

2.7

2.8

1.34

1.29

ug/l

0.10

148

573

Diseases of arteries, arterioles and capillaries

101

544

1.39

2.51

2.0

2.2

1.77

0.99

ug/l

1.12

512

Other specified and unspecified strabismus

4.43

2.48

2.6

4.3

0.85

1.36

ug/l

—

Gonarthrosis,primary

146

701

1.31

2.47

2.1

0.86

1.02

ug/l

0.66

135

665

Hypoplasia of dental enamel, including avohilmo

2.25

2.46

4.6

6.4

2.83

2.01

ug/l

0.55

Other disorders of nervous system

2.39

2.46

1.9

2.7

1.37

1.16

ug/l

0.10

Other/unspecified synovitis and tenosynovitis

123

1.96

2.44

1.2

2.8

1.04

0.94

ug/l

0.11

118

Neuromuscular dysfunction of bladder

2.14

2.44

2.1

2.3

0.76

1.10

ug/l

0.59

Pain in thoracic spine

166

1.81

2.44

2.0

2.4

0.57

1.19

ug/l

2.78

151

Other disorders of eye and adnexa

196

1.74

2.42

2.6

2.9

1.25

1.43

ug/l

0.19

181

Maxillary retrognathism

2.97

2.42

6.5

4.4

0.67

1.21

ug/l

—

Congenital malformations and deformations of the musculoskeletal system

226

1.68

2.38

3.4

4.2

1.29

1.76

ug/l

0.99

218

Varus deformity, not elsewhere classified

6.31

2.38

5.0

2.9

1.51

0.97

ug/l

—

Other heart diseases, wide

223

1119

1.24

2.37

2.0

2.7

1.49

1.14

ug/l

0.84

206

1054

Dental caries, including avohilmo

168

669

1.28

2.37

2.7

2.8

1.22

1.27

ug/l

0.10

159

635

Persons encountering health services in circumstances related to reproduction

158

833

1.29

2.37

3.3

2.6

1.29

1.17

ug/l

0.25

150

770

Dental caries 1

168

669

1.28

2.37

2.7

2.8

1.22

1.27

ug/l

0.10

159

635

Transplanted organ and tissue status

139

1.88

2.36

3.4

3.7

2.88

1.51

ug/l

1.76

130

Dental caries 2 and operation codes

183

1156

1.26

2.35

2.8

2.6

1.31

1.19

ug/l

0.33

173

1089

Anosmia

6.20

2.35

2.0

1.4

0.33

0.64

ug/l

—

Dental caries 2

186

1165

1.26

2.34

2.8

2.6

1.32

1.19

ug/l

0.37

176

1096

Other congenital malformations of nervous system

3.53

2.28

6.9

4.9

1.66

1.56

ug/l

—

Open wound of neck

5.63

2.22

1.0

3.3

0.52

2.03

ug/l

—

Glucagon-like peptide-1 (GLP-1) analogues

463

1.40

2.20

1.9

2.1

0.88

0.93

ug/l

0.09

442

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

2.40

2.20

1.9

2.7

1.38

ug/l

0.00

Other skin changes

187

1.71

2.20

2.0

2.6

1.43

1.14

ug/l

0.34

176

Injuries to the ankle and foot

164

1187

1.26

2.19

2.0

2.7

1.17

1.16

ug/l

0.01

152

1115

Other heart diseases

117

584

1.32

2.19

2.0

2.9

1.46

1.10

ug/l

0.81

108

552

Dialysis, with operation codes

165

1.76

2.18

2.9

3.2

2.93

1.37

ug/l

1.72

155

Hernia of abdominal wall

575

1.39

2.18

2.0

2.5

1.21

1.07

ug/l

0.24

543

Redundant prepuce, phimosis and paraphimosis

303

1.55

2.16

2.4

2.7

1.03

0.85

ug/l

0.24

274

Complications associated with artificial fertilization

4.31

2.15

1.5

2.9

1.14

1.53

ug/l

—

Monoamine oxidase A inhibitors

115

1.92

2.15

1.2

2.4

0.62

1.13

ug/l

1.30

105

Cerebrovascular diseases

113

612

1.32

2.14

2.1

2.3

1.16

0.97

ug/l

0.47

106

578

Excessive attrition of teeth

387

1.36

2.11

2.6

2.7

1.20

1.11

ug/l

0.19

362

Anorexia (incl.atypical)

2.05

2.11

1.7

2.4

1.29

1.23

ug/l

0.06

Dental caries 2, only avohilmo

182

1158

1.24

2.10

2.8

2.6

1.29

1.17

ug/l

0.33

172

1090

L01XX Other antineoplastic agents

2.71

2.10

2.7

1.8

1.29

1.52

ug/l

—

Monosomies and deletions from the autosomes, not elsewhere classified

3.70

2.10

3.7

6.5

4.07

2.73

ug/l

—

Diseases of liver

396

1.47

2.10

2.2

2.3

1.26

0.99

ug/l

0.43

371

ILD medications: immunosuppressive drugs

135

1012

1.28

2.09

2.2

2.8

1.40

1.21

ug/l

0.52

126

957

Symptoms and signs involving appearance and behaviour

5.06

2.08

1.0

3.8

1.52

3.08

ug/l

—

Open bite that required surgery (Lefort1 or BSSRO)

5.05

2.07

1.0

2.3

0.93

1.68

ug/l

—

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

5.04

2.07

1.0

2.6

0.97

1.28

ug/l

—

Personality and behavioural disorders due to brain disease, damage and dysfunction

5.03

2.07

1.0

1.8

0.71

1.15

ug/l

—

Open wound of wrist and hand

711

1.34

2.06

1.8

2.4

0.97

1.10

ug/l

0.34

655

Leisure time condition

253

1.58

2.05

1.8

2.7

1.67

1.28

ug/l

0.36

235

Iron deficiency anaemia secondary to blood loss (chronic)

139

1.80

2.04

1.4

2.3

1.67

1.25

ug/l

0.29

132

Atopic dermatitis

137

919

1.27

2.01

2.8

1.21

1.26

ug/l

0.11

129

871

Other and unspecified injuries of ankle and foot

2.23

2.01

1.9

3.0

2.08

1.02

ug/l

1.04

Coxarthrosis [arthrosis of hip](FG)

432

1.37

2.00

3.3

2.1

1.19

0.96

ug/l

0.41

413

Hypermetropia

148

1.76

1.98

3.7

4.3

1.48

1.58

ug/l

0.10

140

Primary_lymphoid and hematopoietic malignant neoplasms

240

1.58

1.97

2.2

2.9

1.08

1.12

ug/l

0.05

224

Contusion of other and unspecified parts of foot

2.09

1.96

2.8

3.2

1.15

1.48

ug/l

0.35

Care involving dialysis

105

1.91

1.95

2.9

3.3

3.18

1.52

ug/l

1.31

Direct fill therapy

249

1.57

1.94

4.3

3.7

1.92

1.48

ug/l

0.50

235

Special screening examination for infectious and parasitic diseases

256

1.49

1.94

2.3

2.2

1.80

1.01

ug/l

1.29

232

Mandibular prognathia

2.75

1.94

7.2

5.0

1.09

1.76

ug/l

—

DVT of lower extremities and pulmonary embolism

402

1.44

1.93

1.6

2.3

0.85

1.02

ug/l

0.38

377

Artificial joint operation, meniscal resection

156

830

1.25

1.93

2.0

2.2

1.04

0.97

ug/l

0.20

147

780

Other disorders involving the immune mechanism, not elsewhere classified

2.46

1.93

2.7

3.7

1.39

1.69

ug/l

0.16

Family history of malignant neoplasm

113

1.86

1.91

3.4

2.1

1.56

0.90

ug/l

0.68

103

Motor disorders

106

1.91

5.7

6.1

2.60

1.93

ug/l

0.53

106

Dental caries 1, only avohilmo

169

696

1.24

1.89

2.6

2.8

1.18

1.29

ug/l

0.34

160

662

Malignant neoplasm of bladder

0.00

1.88

0.0

1.5

—

1.12

—

Other maternal disorders predominantly related to pregnancy

118

576

1.29

1.86

2.0

2.2

1.33

1.23

ug/l

0.19

112

556

Macular pucker

107

1.87

1.85

2.4

1.9

0.71

1.10

ug/l

0.71

100

Scarlet fever

4.23

1.83

1.2

3.8

0.18

1.31

ug/l

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

180

960

1.22

1.81

2.3

1.41

1.03

ug/l

0.83

167

909

Melanocytic naevi, other sites/unspecified

1.92

1.80

2.4

2.1

1.33

1.20

ug/l

0.14

Erosion of teeth, including avohilmo

308

1.48

1.79

2.2

2.6

1.47

1.01

ug/l

0.79

287

Unspecified fall

747

1.30

1.79

2.4

2.9

0.84

1.27

ug/l

2.69

703

Diseases of appendix

154

1140

1.23

1.76

1.9

2.2

1.21

1.03

ug/l

0.40

143

1065

Suggestive for eosinophilic asthma

1.90

1.75

2.4

2.1

0.71

1.04

ug/l

0.67

Outcome of delivery

210

0.56

1.74

2.7

1.9

1.22

1.04

ug/l

0.17

199

Other diseases of stomach and duodenum

2.23

1.74

1.6

1.9

1.63

1.14

ug/l

0.21

Personal history of risk-factors, not elsewhere classified

3.87

1.72

3.6

3.2

1.62

2.90

ug/l

—

Benign neoplasm: Lip

3.86

1.71

4.2

2.3

0.81

1.06

ug/l

—

Labour and delivery complicated by fetal stress [distress]

324

0.64

1.71

2.2

2.0

1.45

1.17

ug/l

0.33

307

Other acquired deformities of musculoskeletal system and connective tissue

2.30

1.70

1.7

2.1

1.15

0.89

ug/l

0.22

Benign neoplasm: Skin of other and unspecified parts of face

1.88

1.70

2.4

1.8

0.48

1.31

ug/l

3.18

Dental caries 3, only avohilmo

178

748

1.22

1.69

2.6

2.9

1.19

1.31

ug/l

0.38

169

711

Appendicitis, broad definition

152

1134

1.23

1.68

1.9

2.3

1.21

1.04

ug/l

0.40

141

1060

5-aminosalicylic acid

316

1.46

1.67

2.1

2.7

1.32

1.19

ug/l

0.25

294

STROKE

101

543

1.29

1.67

2.4

2.3

1.24

0.99

ug/l

0.57

514

Primary_lymphoid and hematopoietic malignant neoplasms

251

1.52

1.67

2.2

2.7

1.08

1.22

ug/l

0.22

235

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

112

720

1.27

1.67

1.9

2.2

1.41

1.13

ug/l

0.69

104

691

Dental caries 3

173

726

1.22

1.66

2.6

2.8

1.21

1.29

ug/l

0.25

165

689

Multiple myeloma and malignant plasma cell neoplasms

2.59

1.66

1.3

1.9

0.92

1.64

ug/l

—

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

119

1.77

1.65

2.6

2.3

0.99

1.12

ug/l

0.14

108

Mandibular prognathia AND surgery (LeFortI or BSSO or LeFortI AND BSSO), including avohilmo

2.83

1.65

6.3

5.6

0.68

1.60

ug/l

—

Other and unspecified rosacea

1.93

1.64

1.4

1.7

1.41

1.25

ug/l

0.07

Noninfectious colitis NAS

173

1.62

1.63

3.0

1.52

1.27

ug/l

0.32

159

Other congenital malformations of male genital organs

2.38

1.62

6.1

6.0

1.48

2.21

ug/l

—

Assault by bodily force

120

1.75

1.62

2.0

2.6

1.45

0.96

ug/l

0.39

110

Biological medicines for asthma

3.60

1.62

1.8

1.7

0.25

1.11

ug/l

—

Somnolence

3.60

1.62

3.4

2.4

0.33

1.44

ug/l

—

Other abnormal findings in urine

3.59

1.62

2.2

3.0

1.15

1.83

ug/l

—

Fetus and newborn affected by maternal conditions that may be unrelated to present pregnancy

2.57

1.61

5.8

6.1

1.94

2.32

ug/l

—

Disorders of sclera, cornea, iris and ciliary body

104

819

1.27

1.61

2.5

2.4

1.09

1.13

ug/l

0.07

767

Fracture of lower leg, including ankle

102

798

1.27

1.61

2.2

2.4

1.07

1.11

ug/l

0.08

746

Respiratory and cardiovascular disorders specific to the perinatal period

155

1.63

1.61

6.1

5.7

2.36

2.14

ug/l

0.19

155

Agranulocytosis

143

1.68

1.60

2.1

2.8

1.54

1.52

ug/l

0.01

133

Chronic respiratory disease originating in the perinatal period

3.14

1.60

6.2

5.9

2.58

2.68

ug/l

—

Acute bronchiolitis

192

1.55

1.58

4.9

4.6

1.99

1.87

ug/l

0.09

185

Benign neoplasm: Skin of other and unspecified parts of face

1.82

1.57

2.4

2.0

0.48

1.16

ug/l

3.02

Acute appendicitis

143

1105

1.22

1.56

1.9

2.3

1.21

1.03

ug/l

0.41

133

1034

Injuries to the elbow and forearm

140

1035

1.22

1.54

2.1

2.6

1.36

1.16

ug/l

0.57

131

976

Hodgkin lymphoma

2.43

1.54

1.6

2.6

0.99

1.74

ug/l

—

Hypospadias

3.41

1.53

5.4

6.1

1.80

3.44

ug/l

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

2.28

1.53

2.9

3.8

1.49

1.61

ug/l

—

Melanocytic naevi, other sites/unspecified

100

1.80

1.53

2.4

2.3

1.33

1.13

ug/l

0.24

Polyarteritis nodosa and related conditions

3.36

1.52

1.2

3.9

2.38

2.26

ug/l

—

Asthma/COPD (KELA code 203)

207

1236

1.18

1.52

2.5

2.6

1.36

1.17

ug/l

0.56

192

1171

Injuries to the shoulder and upper arm

159

1105

1.21

1.52

1.8

2.5

1.13

1.05

ug/l

0.18

146

1032

Malignant neoplasm, wide definition for exclusion

189

937

1.19

1.52

2.5

1.28

1.11

ug/l

0.47

179

880

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

189

937

1.19

1.52

2.5

1.28

1.11

ug/l

0.47

179

880

Benign neoplasm of eye and adnexa

1.83

1.51

2.2

2.1

3.51

1.18

ug/l

0.55

Benign neoplasm of eye and adnexa

1.83

1.51

2.2

1.9

3.51

1.19

ug/l

0.55

Antenatal screening

252

0.65

1.50

1.7

1.9

0.90

1.04

ug/l

0.31

238

Gonarthrosis, primary, with knee surgery

452

1.32

1.48

2.0

2.1

1.01

1.07

ug/l

0.11

431

Pre-eclampsia or eclampsia

300

1.44

1.48

1.5

2.2

1.21

1.22

ug/l

0.02

283

Other chromosome abnormalities, not elsewhere classified

2.57

1.47

4.9

6.5

2.00

2.57

ug/l

—

Fall on same level involving ice and snow

100

796

1.26

1.45

2.2

2.3

1.12

1.07

ug/l

0.08

751

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

2.12

1.44

3.6

2.9

0.69

1.57

ug/l

1.06

Cyst of kidney

2.04

1.43

1.1

1.8

0.54

1.27

ug/l

1.06

Hypoplasia of dental enamel, prenatal , including avohilmo

2.25

1.43

4.9

6.3

3.18

2.42

ug/l

—

Coxarthrosis, primary

507

1.30

1.42

3.4

2.1

1.28

1.01

ug/l

0.47

488

Sudden idiopathic hearing loss

1.82

1.41

1.7

1.9

0.50

1.18

ug/l

2.20

Pre-eclampsia

280

1.43

1.37

1.5

2.2

1.18

1.23

ug/l

0.08

264

Routine general health check-up of defined subpopulation

2.62

1.37

2.8

3.2

7.22

1.23

ug/l

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

442

1.34

1.36

1.4

2.4

1.00

1.21

ug/l

0.40

412

Congenital malformations of cardiac chambers and connections

0.00

1.35

0.0

6.1

—

1.65

—

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

187

938

1.18

1.35

2.5

1.29

1.11

ug/l

0.51

177

881

Hypoplasia of dental enamel, prenatal

2.54

1.35

4.5

6.4

3.85

2.55

ug/l

—

Other and unspecified urticaria

324

1.39

1.33

2.7

3.0

1.18

1.37

ug/l

0.31

307

Inflammatory diseases of prostate (prostatitis)

113

1.68

1.31

2.3

2.7

0.65

0.66

ug/l

0.01

106

Varicose veins

527

1.26

1.30

2.7

2.1

1.46

1.02

ug/l

0.50

506

Pre-eclampsia or poor fetal growth

480

1.31

1.28

1.7

2.2

1.09

1.32

ug/l

0.63

457

Primary gonarthrosis, bilateral

436

1.30

1.27

2.0

2.2

0.97

1.01

ug/l

0.06

415

Allergic colitis

1.80

1.27

4.9

5.7

3.06

2.06

ug/l

0.41

Second line medication for Crohn's disease

112

920

1.22

1.26

2.2

2.7

1.37

1.19

ug/l

0.45

106

867

Other inflammation of eyelid

154

1.56

1.25

2.2

2.9

0.90

1.35

ug/l

0.60

144

Seborrhoeic dermatitis

115

1.66

1.24

1.8

2.6

1.98

1.18

ug/l

0.44

106

Congenital malformations of ovaries, fallopian tubes and broad ligaments

1.86

1.24

1.2

2.3

0.83

1.09

ug/l

0.34

Other inflammatory liver diseases

1.86

1.23

1.2

2.4

2.17

1.16

ug/l

0.46

Other disorders of bone

295

1.39

1.23

1.4

2.5

0.74

1.05

ug/l

0.93

273

Fracture of lumbar spine and pelvis

195

1.49

1.23

1.3

2.3

1.79

1.14

ug/l

1.03

183

Acute appendicitis, no complications

114

939

1.21

1.22

2.0

2.3

1.08

1.07

ug/l

0.03

107

874

L04AX Other immunosuppressants

108

887

1.22

2.3

2.7

1.37

1.20

ug/l

0.38

102

838

Phakomatoses, not elsewhere classified

2.65

1.22

2.0

3.7

0.37

1.85

ug/l

—

Statin medication

149

703

1.19

1.21

2.2

2.3

1.12

1.08

ug/l

0.08

131

656

Complications of labour and delivery

567

0.80

1.21

1.9

2.1

1.28

1.19

ug/l

0.17

548

Psoriasis

348

1.35

1.20

2.9

2.3

1.26

0.92

ug/l

0.33

323

Thyroiditis

1.75

1.19

1.7

2.2

2.07

1.04

ug/l

0.73

Benign neoplasm: Transverse colon

1.75

1.18

7.5

2.0

0.68

1.03

ug/l

0.75

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

109

1.66

1.18

1.1

2.0

0.93

1.07

ug/l

0.24

103

Perineal laceration during delivery

267

0.63

1.18

2.1

2.06

1.02

ug/l

0.80

250

Delirium, not induced by alcohol and other psychoactive substances

1.74

1.18

2.1

1.8

2.45

1.24

ug/l

0.58

Myocardial infarction, strict

383

0.72

1.18

1.3

2.4

1.42

0.98

ug/l

0.48

358

Recurrent dislocation of patella

1.88

1.18

1.9

2.9

1.17

0.98

ug/l

0.14

Other disorders of conjunctiva

141

1.56

1.17

1.9

2.3

0.78

1.27

ug/l

0.97

129

Parodontitis and operation codes

150

990

1.18

1.17

2.7

2.1

1.14

1.02

ug/l

0.29

141

926

Adjustment and management of implanted device

149

1.55

1.16

2.2

2.5

1.01

1.24

ug/l

0.28

142

Pervasive developmental disorders excl. Autism + Asperger

1.94

1.16

4.7

5.9

2.15

2.12

ug/l

0.02

Postmenopausal atrophic vaginitis

132

1.46

1.16

1.7

1.9

1.29

1.11

ug/l

0.25

125

Cardiodefibrillation

324

1.36

1.16

2.1

1.05

ug/l

0.00

306

Fibrosis and cirrhosis of liver

1.81

1.15

4.8

2.0

2.50

1.30

ug/l

0.56

Superficial injury of shoulder and upper arm

152

0.53

1.14

1.1

2.5

0.78

1.18

ug/l

—

135

Injury of muscle and tendon at shoulder and upper arm level

395

1.32

1.13

1.3

2.3

0.94

ug/l

0.00

369

Striking against or struck by other objects

589

1.26

1.13

2.3

2.8

1.57

1.18

ug/l

0.71

542

Coxarthrosis, primary, with hip surgery

383

1.31

1.12

4.1

2.0

1.47

0.98

ug/l

0.71

369

conjunctival haemorrhage

1.78

1.10

1.7

2.4

0.95

1.73

ug/l

0.92

Conduction disorders

258

1.35

1.08

1.6

2.8

1.34

1.14

ug/l

0.16

245

111

831

1.20

1.07

1.6

2.2

1.15

0.92

ug/l

0.53

100

761

Fracture of shoulder and upper arm

488

1.27

1.05

1.9

2.8

1.69

1.17

ug/l

0.83

458

Drug-induced neutropenia

1.79

1.04

1.5

1.9

0.53

1.27

ug/l

1.78

Retinal detachment with retinal break

125

0.48

1.04

5.8

2.2

0.64

1.13

ug/l

—

116

Insulin, intermediate and long-acting

772

1.21

1.03

2.2

2.7

1.81

1.04

ug/l

1.17

724

Recurrent dislocation and subluxation of joint

1.65

1.00

3.5

2.1

0.63

0.89

ug/l

0.53

Abdominal aortic aneurysm (AAA)

1.87

0.99

2.8

1.5

0.41

0.81

ug/l

—

Hordeolum and other deep inflammation of eyelid

1.71

0.99

2.6

3.1

0.95

1.47

ug/l

0.63

Congenital malformations of gallbladder, bile ducts and liver

2.19

0.98

5.6

5.4

4.07

1.72

ug/l

—

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

2.19

0.98

4.0

5.0

1.39

1.04

ug/l

—

Perforation of tympanic membrane

134

0.52

0.98

2.3

3.0

1.53

1.27

ug/l

—

125

Myositis

2.18

0.98

1.6

3.7

0.60

1.11

ug/l

—

Benign neoplasm: Transverse colon

1.63

0.97

7.5

1.8

0.68

1.24

ug/l

1.31

Melanocytic naevi of other and unspecified parts of face

1.74

0.96

2.7

1.8

1.44

1.07

ug/l

0.35

Other retinal disorders

586

1.21

0.94

2.1

2.3

1.61

1.00

ug/l

1.17

555

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

101

1.59

0.93

3.3

2.1

0.63

0.86

ug/l

0.48

Melanocytic naevi of other and unspecified parts of face

1.72

0.92

2.7

2.1

1.44

1.17

ug/l

0.24

Hypertrophy of breast in women and men

243

1.36

0.92

1.6

2.3

0.64

1.16

ug/l

2.16

227

Molar incisor enamel hypoplasia, with caries

1.69

0.92

4.9

6.2

1.57

1.95

ug/l

0.45

Insulin, combination of fast acting with intermediate-acting or long-acting

106

828

1.18

0.92

2.2

2.7

1.69

1.06

ug/l

1.00

776

Glomerular disorders in diseases classified elsewhere

126

1.51

0.91

2.0

2.5

2.39

1.15

ug/l

0.95

115

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

117

1.54

0.90

5.9

2.18

2.48

ug/l

0.27

117

Respiratory distress of newborn

125

1.50

0.90

5.9

6.0

2.59

2.38

ug/l

0.15

125

Stroke, including SAH

496

1.21

0.89

2.3

1.31

0.97

ug/l

0.75

472

Retinal breaks without detachment

160

1.44

0.88

3.5

2.2

0.48

0.96

ug/l

2.85

150

Insulin medication

106

771

1.18

0.88

2.2

2.7

1.69

1.08

ug/l

0.95

729

Injury of muscle and tendon at hip and thigh level

119

1.52

0.88

1.9

2.7

1.18

1.06

ug/l

0.11

109

Oral lichen ruber planus, including avohilmo

1.79

0.87

1.0

2.2

0.73

1.46

ug/l

—

Desensitization to allergens

1.58

0.87

2.8

3.0

0.68

1.09

ug/l

0.86

Car occupant injured in other and unspecified transport accidents

281

1.32

0.86

1.6

2.3

0.84

1.23

ug/l

0.73

260

Transient ischemic attack

416

1.24

0.86

2.5

2.3

1.29

0.92

ug/l

0.61

400

Meningitis

1.72

0.86

5.6

2.1

0.87

1.42

ug/l

0.74

Other condition

195

1.39

0.86

1.9

2.5

1.52

1.17

ug/l

0.43

177

Varicella [chickenpox]

1.57

0.84

1.9

4.1

0.60

1.74

ug/l

3.60

Other dialysis

1.78

0.84

3.6

3.1

2.41

1.20

ug/l

—

Inguinal hernia, bilateral

104

1.54

0.84

4.4

2.6

1.87

1.15

ug/l

0.60

Inguinal or femoral hernia, bilateral

104

1.54

0.84

4.4

2.6

1.87

1.15

ug/l

0.60

Pedal cyclist injured in other and unspecified transport accidents

162

1.42

0.84

1.5

2.7

0.88

1.18

ug/l

0.42

147

Mycoses

327

1.29

0.83

1.6

2.6

1.00

1.13

ug/l

0.26

306

Malignant neoplasm of breast, HER-positive

349

0.73

0.82

1.5

2.2

2.47

1.07

ug/l

1.14

336

Fracture of forearm

774

1.17

0.82

2.1

2.6

1.40

1.08

ug/l

0.77

731

Dental caries 1 and operation codes, only avohilmo

284

1.22

0.81

2.8

3.5

1.23

1.46

ug/l

0.46

272

Mental and behavioural disorders due to alcohol

734

1.18

0.81

1.6

2.1

1.07

0.94

ug/l

0.23

673

Otitis externa, unspecified

155

1.42

0.81

1.8

3.1

0.87

1.38

ug/l

1.13

145

Alcohol use disorder, ICD-based

590

1.20

0.80

1.6

2.2

1.15

0.96

ug/l

0.31

543

Congenital malformations of larynx

0.00

0.80

0.0

6.0

—

2.51

—

All dysplastic lesions of the cervix uteri

430

0.77

0.79

2.5

2.1

1.45

1.31

ug/l

0.13

411

Alcohol use disorder, Swedish definition

753

1.17

0.79

1.7

2.2

1.20

0.91

ug/l

0.64

690

Other and unspecified psoriasis

1.67

0.78

2.1

1.9

0.43

1.29

ug/l

2.06

Multiple delivery

125

0.56

0.77

1.9

1.8

0.37

1.12

ug/l

—

118

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

123

1.46

0.77

2.3

2.0

0.97

ug/l

0.00

113

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

284

0.74

0.77

1.5

2.3

2.47

1.08

ug/l

1.12

273

Sacroiliitis, not elsewhere classified

1.70

0.75

3.7

2.7

0.64

1.22

ug/l

—

Osteonecrosis

1.70

0.75

2.1

2.3

1.04

1.15

ug/l

—

Motorcycle rider injured in other and unspecified transport accidents

1.54

0.75

1.4

2.8

0.65

1.39

ug/l

1.57

Other congenital malformations of limb(s)

2.10

0.75

5.4

5.2

1.60

2.54

ug/l

—

Stroke, excluding SAH

461

1.19

0.75

2.4

2.3

1.31

1.00

ug/l

0.61

439

Coagulation defects, purpura and other haemorrhagic conditions

262

1.30

0.74

1.8

3.1

1.35

1.30

ug/l

0.03

246

Retained placenta and membranes, without haemorrhage

160

0.62

0.73

1.7

2.2

1.13

1.10

ug/l

—

151

Parodontitis

153

1002

1.13

0.73

2.7

2.1

1.13

1.03

ug/l

0.24

143

939

Spirochaetal infections, other/unspecified

1.52

0.72

1.6

2.1

1.31

1.53

ug/l

0.17

Other mental disorders due to brain damage and dysfunction and to physical disease

1.52

0.72

4.4

1.8

1.18

1.14

ug/l

0.05

Parodontitis or operation codes

153

1003

1.12

0.71

2.7

2.1

1.13

1.03

ug/l

0.24

143

939

Benign neoplasm: Skin, unspecified

1.75

0.71

4.6

2.5

1.71

1.30

ug/l

—

Embedded teeth, including avohilmo

151

1.39

0.71

3.3

2.4

1.21

1.09

ug/l

0.10

137

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

107

1.48

0.71

6.3

6.0

1.92

2.40

ug/l

0.49

107

Juvenile arthritis (FINNGEN)

109

1.47

0.71

1.3

4.1

0.55

1.58

ug/l

4.02

103

Transitory endocrine and metabolic disorders specific to fetus and newborn

107

1.48

0.70

6.3

6.0

1.92

2.40

ug/l

0.49

107

Chronic periodontitis, including avohilmo

152

1002

1.12

0.70

2.7

2.1

1.13

1.02

ug/l

0.28

143

937

Malignant neoplasm

172

914

1.12

0.70

2.4

2.5

1.34

1.12

ug/l

0.60

164

862

100

797

1.15

0.70

1.6

2.2

1.07

0.92

ug/l

0.32

733

Malignant melanoma of skin

101

1.49

0.70

2.5

1.7

1.15

1.23

ug/l

0.07

Pedal cyclist injured in transport accident

345

1.25

0.70

1.7

2.6

1.38

1.14

ug/l

0.28

321

Other and unspecified mental retardation

1.54

0.69

4.0

6.0

1.32

2.37

ug/l

1.81

Papulosquamous disorders

500

1.20

0.69

2.6

2.4

1.11

1.01

ug/l

0.11

470

Alcohol dependence

346

1.24

0.68

1.6

2.3

1.35

1.00

ug/l

0.40

324

Pneumonia due to other infectious organisms, not elsewhere classified

1.67

0.68

2.4

2.5

0.35

1.32

ug/l

—

Benign neoplasm: Skin, unspecified

1.67

0.68

4.6

2.7

1.71

1.42

ug/l

—

Obstructed labour due to maternal pelvic abnormality

180

0.67

2.8

2.1

1.03

1.06

ug/l

0.03

174

Covid-19 suspected case

352

0.77

0.67

3.2

2.5

0.99

1.21

ug/l

0.40

326

Conjunctivitis (acute, non atopic)

482

1.20

0.66

3.0

3.2

1.19

1.43

ug/l

0.53

453

Disorders of continuity of bone

119

1.43

0.66

3.5

2.3

1.54

1.29

ug/l

0.27

107

Degenerative macular diseases

1.49

0.66

3.0

1.9

1.34

1.14

ug/l

0.08

Codes for special purposes

724

1.16

0.66

2.3

2.5

1.16

1.25

ug/l

0.17

684

Provisional assignment of new diseases of uncertain etiology

724

1.16

0.66

2.3

2.5

1.16

1.25

ug/l

0.17

684

Inguinal hernia

110

650

1.14

0.66

2.8

2.3

1.44

1.02

ug/l

1.02

105

600

Sulfasalazine

375

1.23

0.66

2.2

2.5

1.67

1.10

ug/l

0.81

351

Other pleural conditions

1.50

0.63

3.4

2.0

0.80

1.34

ug/l

1.04

Fetus and newborn affected by noxious influences transmitted via placenta or breast milk

0.00

0.62

0.0

6.9

—

2.92

—

Thrombocytopenia, unspecified

1.52

0.62

1.5

2.8

0.95

1.65

ug/l

1.15

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

1.52

0.62

4.8

2.1

0.85

1.09

ug/l

0.18

Other disorders of white blood cells

1.59

0.61

1.5

2.4

1.17

1.63

ug/l

—

Other congenital malformations, not elsewhere classified

1.68

0.61

5.0

5.8

1.65

1.90

ug/l

—

Other congenital malformations of ear

1.67

0.61

1.8

5.6

2.40

2.18

ug/l

—

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

1.59

0.61

1.6

1.9

1.04

1.26

ug/l

—

Benign neoplasm: Choroid

1.60

0.61

1.1

1.9

2.15

1.30

ug/l

—

Use of antiglaucoma preparations and miotics

1.60

0.61

1.0

1.8

3.94

1.48

ug/l

—

Oral leukoplakia and related diseases

1.57

0.60

1.6

2.0

1.84

1.14

ug/l

—

Undefined dementia

1.53

0.59

1.8

1.4

2.53

1.35

ug/l

—

Familial hypercholesterolemia

114

1.40

0.58

1.0

2.3

1.45

1.09

ug/l

0.28

107

Mental and behavioural disorders due to alcohol, excluding acute intoxication

639

1.16

0.58

1.6

2.1

1.12

0.95

ug/l

0.29

586

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

1.56

0.58

3.9

1.7

0.94

1.35

ug/l

—

Heart failure and coronary heart disease

190

0.74

0.58

1.2

2.2

1.13

1.05

ug/l

0.11

179

Other medical care

436

1.19

0.57

2.7

2.5

1.51

1.08

ug/l

0.28

412

Unspecified dementia

1.47

0.56

1.8

1.4

2.53

1.52

ug/l

—

Coronary artery bypass grafting

184

0.74

0.56

1.4

2.1

1.01

0.81

ug/l

0.31

172

Ischaemic Stroke, excluding all haemorrhages

428

1.17

0.56

2.4

2.3

1.07

1.03

ug/l

0.07

409

Benign neoplasm: Choroid

1.46

0.56

1.1

1.8

2.15

1.39

ug/l

—

Dental caries 3 and operation codes, only avohilmo

330

1.16

0.55

2.7

3.5

1.24

1.47

ug/l

0.53

315

Bacterial meningitis

1.62

0.55

4.0

1.9

1.08

0.83

ug/l

—

Benign neoplasm of urinary organs

1.62

0.55

1.0

1.7

3.37

1.55

ug/l

—

Carcinoma in situ of cervix uteri

133

1.36

0.55

2.2

1.9

1.53

1.12

ug/l

0.26

124

Alcohol-induced acute pancreatitis

1.58

0.54

1.0

2.4

2.49

0.97

ug/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

1.47

0.54

4.8

2.1

0.85

1.18

ug/l

0.25

Medical treatment for female infertility

357

1.20

0.53

3.6

2.1

1.15

1.30

ug/l

0.24

343

Acute peritonitis

1.48

0.53

2.7

2.2

3.95

1.24

ug/l

—

Otalgia

125

1.36

0.53

2.4

3.7

0.73

1.59

ug/l

1.96

120

Familial hypercholesterolemia, with ischemic heart disease

1.52

0.52

1.0

1.7

1.55

1.01

ug/l

—

All dysplastic lesions of the cervix uteri, vagina or vulva

466

0.83

0.52

2.3

2.1

1.52

1.29

ug/l

0.25

446

Crowding of teeth, including avohilmo

228

1.23

0.52

4.2

3.9

1.73

1.60

ug/l

0.13

220

Cardiovascular disorders originating in the perinatal period

1.52

0.52

6.7

6.0

3.00

2.45

ug/l

—

Myocardial infarction, with ST-elevation

134

0.67

0.51

1.1

2.3

2.70

1.09

ug/l

—

123

Purpura and other haemorrhagic conditions

188

1.28

0.51

2.1

3.0

1.11

1.45

ug/l

0.43

175

Carcinoma in situ of cervix uteri

135

1.33

0.51

2.2

2.0

1.53

1.11

ug/l

0.27

125

Benign neoplasm of bone and articular cartilage

109

1.38

0.51

1.5

2.4

0.90

1.41

ug/l

0.66

Missing teeth due to accident, extraction or parodontitis

109

1.38

0.50

4.3

2.1

0.83

1.06

ug/l

0.38

101

Supervision of normal pregnancy

243

0.82

0.50

2.1

1.9

1.10

1.03

ug/l

0.09

229

Injury of other and unspecified intrathoracic organs

1.49

0.49

2.4

2.5

0.65

1.16

ug/l

—

Intrahepatic Cholestasis of Pregnancy (ICP)

109

0.64

0.48

3.3

2.3

1.30

1.03

ug/l

—

102

Medical abortion

538

0.89

0.48

2.1

2.0

1.12

1.24

ug/l

0.28

519

L04AD Calcineurin inhibitors

190

1.26

0.47

3.8

3.7

2.64

1.45

ug/l

1.33

176

Congenital deformities of hip

1.46

0.47

2.3

5.0

2.39

2.21

ug/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

118

0.68

0.45

3.6

2.2

1.17

1.05

ug/l

—

110

L02BA Anti-estrogens

153

0.72

0.45

1.5

2.1

0.86

1.10

ug/l

0.44

147

Abnormal findings on antenatal screening of mother

138

1.31

0.45

3.4

2.1

0.68

1.18

ug/l

1.65

131

Viral warts

156

1.28

0.45

3.5

2.9

1.44

1.39

ug/l

0.03

143

Benign neoplasm of bone and articular cartilage

112

1.34

0.44

1.5

2.3

0.90

1.46

ug/l

0.75

103

Other and unspecified coagulation defects

1.45

0.44

1.0

2.7

1.89

1.12

ug/l

—

Emergency coronary revascularization (for ACS)

385

0.86

0.44

1.9

2.2

1.07

1.01

ug/l

0.09

363

Squamous cell neoplasms and carcinomas of the skin

1.45

0.44

1.6

1.04

1.30

ug/l

—

Congenital malformations of the musculoskeletal system, not elsewhere classified

1.62

0.43

1.2

3.9

0.66

1.91

ug/l

—

Other and unspecified disorders of psychological development

1.41

0.42

5.4

5.8

3.05

2.03

ug/l

—

Amiodarone users

0.64

0.42

1.0

2.1

1.09

1.28

ug/l

—

Dental caries 2 and operation codes, only avohilmo

154

882

1.08

0.42

2.7

2.6

1.24

1.16

ug/l

0.17

144

828

Fetus and newborn affected by maternal complications of pregnancy

1.39

0.42

5.9

6.3

2.76

2.58

ug/l

—

Prolonged pregnancy

249

0.81

0.42

2.0

2.1

0.65

1.27

ug/l

1.98

236

Dislocation, sprain and strain of joints and ligaments of head

1.43

0.41

1.9

3.7

2.58

1.65

ug/l

—

Diabetic neuropathy

138

0.72

0.41

1.1

2.2

2.04

1.05

ug/l

—

127

Coronary revascularization (ANGIO or CABG)

349

0.86

0.41

2.0

2.4

1.06

0.99

ug/l

0.11

328

Defects in the complement system

0.00

0.41

0.0

5.4

—

2.54

—

Mental and behavioural disorders of puerperium, not classified elsewhere

0.00

0.41

0.0

1.8

—

1.53

—

Carcinoma in situ of cervix uteri, endocervix

0.00

0.41

0.0

1.7

—

1.22

—

Carcinoma in situ of cervix uteri, endocervix

0.00

0.41

0.0

1.5

—

0.99

—

Gender identity disorders

0.00

0.41

0.0

2.1

—

1.43

—

Caries in Clefts patients

0.00

0.41

0.0

4.0

—

1.82

—

Seronegative rheumatoid arthritis

114

1.32

0.40

2.6

2.4

1.49

1.24

ug/l

0.16

108

Tonsillectomy and adenotomy

145

933

1.08

0.40

2.7

2.8

1.26

1.27

ug/l

0.03

134

873

Cleft palate

0.00

0.40

0.0

4.6

—

1.67

—

Anorexia

0.00

0.40

0.0

2.9

—

1.29

—

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

103

0.68

0.39

1.1

2.1

0.40

1.20

ug/l

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

692

1.11

0.38

2.0

2.6

1.08

1.17

ug/l

0.16

646

Contraceptive management

533

1.11

0.38

1.9

2.0

0.78

0.92

ug/l

0.51

488

Other diseases of biliary tract

1.38

0.38

1.3

2.3

1.11

1.60

ug/l

0.40

Follicular lymphoma

1.39

0.38

3.0

1.9

0.28

1.75

ug/l

—

Poor fetal growth

206

1.21

0.37

1.9

2.2

0.78

1.24

ug/l

1.25

194

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

113

0.71

0.37

3.6

2.1

1.17

1.16

ug/l

—

108

Otosclerosis

1.39

0.37

2.0

2.3

0.80

1.27

ug/l

—

Psoriasis vulgaris

235

1.19

0.36

2.9

2.2

0.53

0.97

ug/l

1.90

219

Osteomyelitis

0.66

0.35

2.4

3.0

0.83

1.68

ug/l

—

Foreign body in alimentary tract

0.65

0.35

3.8

3.1

1.09

1.73

ug/l

—

Other and unspecified injuries of head

0.65

0.35

3.0

3.1

1.35

1.61

ug/l

—

Polypectomy (DHB20)

0.65

0.35

3.8

2.6

0.74

1.23

ug/l

—

Benign neoplasm of urinary organs

1.43

0.35

1.0

2.0

3.37

1.33

ug/l

—

Impacted cerumen

108

1.30

0.35

3.3

2.9

1.56

1.55

ug/l

0.01

102

Other complications of labour and delivery, not elsewhere classified

204

0.80

0.35

3.8

2.2

0.77

1.12

ug/l

0.63

191

Chronic pancreatitis

126

1.27

0.35

3.1

2.1

2.45

1.13

ug/l

0.71

116

Salpingitis and oophoritis

199

1.21

0.35

1.3

2.2

1.17

ug/l

0.00

188

Cysts of oral region, not elsewhere classified

1.36

0.34

3.2

2.6

0.65

1.21

ug/l

—

Hard cardiovascular diseases

115

681

1.08

0.34

2.2

2.3

1.34

0.98

ug/l

0.99

110

638

Presence of other devices

172

1.22

0.34

2.2

2.1

1.69

1.06

ug/l

0.51

162

Injury of unspecified body region

100

1.30

0.33

1.2

2.9

1.21

1.48

ug/l

0.20

Glomerular diseases

237

1.18

0.33

2.1

2.9

1.89

1.30

ug/l

0.55

220

Benign mammary dysplasia

127

1.26

0.33

1.8

2.2

1.08

1.20

ug/l

0.09

121

Glomerulonephritis

155

0.77

0.33

2.7

3.4

1.47

1.42

ug/l

0.03

144

Cardiac arrest

1.29

0.32

1.2

2.8

1.56

1.17

ug/l

—

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

201

1.19

0.32

1.6

2.3

0.98

0.86

ug/l

0.21

187

Contact with nonpowered hand tool

1.32

0.31

1.1

2.2

1.84

1.35

ug/l

—

L01XE Protein kinase inhibitors

1.32

0.30

1.0

1.9

1.46

1.31

ug/l

—

Twin gestation

138

1.23

0.30

2.3

2.4

0.51

1.15

ug/l

2.30

131

Other diseases of pancreas

1.33

0.30

1.3

2.1

0.66

1.46

ug/l

—

Inflammatory disorders of breast

1.31

0.30

2.5

2.3

0.99

1.08

ug/l

0.07

Adalimumab

129

0.77

0.28

1.5

2.7

0.64

0.98

ug/l

—

120

Disorders of choroid and retina

113

768

1.07

0.28

2.3

1.38

1.02

ug/l

0.76

107

726

Ascites

1.27

0.27

1.6

2.4

1.21

1.19

ug/l

—

Pleural plaque

1.27

0.27

1.8

1.3

0.89

0.85

ug/l

—

Glaucoma, exfoliation

1.27

0.27

1.4

1.9

1.00

1.25

ug/l

—

Use of memantine

104

0.75

0.27

2.1

1.6

0.44

1.48

ug/l

—

Use of other anti-dementia drugs

104

0.75

0.27

2.1

1.6

0.44

1.48

ug/l

—

Postprocedural musculoskeletal disorders, not elsewhere classified

1.25

0.27

1.0

1.9

0.62

1.20

ug/l

—

Secondary uncertain malignant neoplasm

122

1.23

0.27

2.6

2.1

1.26

1.20

ug/l

0.04

111

Other congenital malformations of tongue, mouth and pharynx

1.21

0.26

5.3

5.5

1.26

2.36

ug/l

—

Pedal cyclist injured in noncollision transport accidents

159

1.20

0.26

1.9

2.9

1.89

1.15

ug/l

0.59

145

Secondary and unspecified malignant neoplasm of lymph nodes

1.28

0.26

3.1

2.1

1.52

1.39

ug/l

0.07

Alcohol-induced chronic pancreatitis

0.68

0.26

2.8

2.6

3.37

1.21

ug/l

—

Other diseases of lip and oral mucosa

160

1.19

0.25

1.4

2.4

1.72

0.94

ug/l

0.58

147

Hypertrophic scar

1.22

0.25

2.7

0.95

0.97

ug/l

—

Amputation

1.22

0.25

1.2

1.8

0.98

0.91

ug/l

—

HSIL lesion of the cervix uteri

277

0.87

0.25

2.7

2.2

1.60

1.19

ug/l

0.33

264

Dementia in Alzheimer disease

1.18

0.24

1.2

1.25

1.38

ug/l

—

Multiple gestation

142

1.20

0.24

2.3

2.4

0.51

1.15

ug/l

2.34

135

Hydrocele

1.25

0.24

2.0

3.2

1.88

1.05

ug/l

0.64

Intracerebral haemorrhage

1.26

0.24

2.3

1.9

2.38

1.30

ug/l

0.44

Scissor bite

0.70

0.24

5.7

5.1

2.57

1.29

ug/l

—

Use of disulfiram, acamprosate or naltrexone

115

1.22

0.23

2.4

2.5

2.48

1.02

ug/l

0.73

102

Other disorders originating in the perinatal period

1.27

0.22

4.8

6.1

1.64

2.07

ug/l

—

Vitamin B12 deficiency anaemia

1.25

0.22

1.7

1.8

0.68

1.28

ug/l

1.20

1.25

0.22

4.8

5.3

1.67

1.43

ug/l

—

Subarachnoid haemorrhage

0.74

0.22

1.4

2.3

1.32

1.30

ug/l

—

Malignant neoplasm of respiratory system and intrathoracic organs

141

1.17

0.22

1.7

2.0

0.99

1.08

ug/l

0.14

132

Disorder of visual pathways, unspecified

0.00

0.21

0.0

5.5

—

0.82

—

Congenital malformations of ear causing impairment of hearing

0.00

0.21

0.0

5.3

—

0.98

—

Mitochondrial myopathy

0.00

0.21

0.0

3.5

—

2.14

—

Cleft hard palate NOS

0.00

0.21

0.0

5.4

—

1.74

—

Pre-eclampsia superimposed on chronic hypertension

0.00

0.21

0.0

2.5

—

1.20

—

Other congenital malformations of upper alimentary tract

0.00

0.21

0.0

4.2

—

3.05

—

Other and unspecified injuries of neck

0.00

0.21

0.0

3.4

—

1.67

—

Burns and corrosions of multiple body regions

0.00

0.21

0.0

3.7

—

1.13

—

Dysplastic lesion of unknown severity of the cervix uteri

0.00

0.21

0.0

2.3

—

1.48

—

Migraine with aura, drug-induced

0.00

0.21

0.0

2.3

—

1.63

—

Other disorders of choroid

0.00

0.21

0.0

2.4

—

2.19

—

Other perinatal haematological disorders

0.00

0.21

0.0

6.2

—

2.46

—

Other congenital malformations of female genitalia

0.00

0.21

0.0

3.1

—

1.47

—

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

0.00

0.21

0.0

2.2

—

1.40

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

1.16

0.21

3.0

1.7

0.54

1.45

ug/l

—

Ill-defined and unknown causes of mortality

1.16

0.21

1.0

1.9

0.34

1.31

ug/l

—

Atrioventricular septal defect

0.00

0.21

0.0

4.8

—

3.13

—

Mental and behavioural disorders associated with the puerperium

0.00

0.21

0.0

1.9

—

1.61

—

Drug-induced hypoglycaemia without coma

0.00

0.21

0.0

2.7

—

1.05

—

Deep bite

243

1.12

0.20

4.5

4.0

1.96

1.42

ug/l

0.59

232

Coeliac disease

183

1.15

0.20

2.4

3.1

1.22

1.35

ug/l

0.13

172

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

105

0.81

0.20

1.2

2.3

1.24

0.99

ug/l

—

Non-small cell lung cancer

115

0.78

0.20

1.2

1.9

1.24

1.20

ug/l

—

106

Neonatal jaundice from other and unspecified causes

123

1.19

0.19

6.2

6.0

3.71

2.13

ug/l

1.23

123

Other disorders of amniotic fluid and membranes

229

1.13

0.19

3.2

2.2

1.50

1.15

ug/l

0.36

218

Abnormal findings on examination of urine, without diagnosis

1.15

0.19

3.3

2.3

1.04

1.82

ug/l

—

Foreign body entering into or through eye or natural orifice

122

0.82

0.19

1.7

3.1

2.01

1.53

ug/l

—

110

Entropion and trichiasis of eyelid

1.15

0.19

1.0

1.9

1.50

1.44

ug/l

—

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

162

1.14

0.19

1.7

2.2

1.14

0.85

ug/l

0.56

149

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

109

1.19

0.18

1.8

2.5

1.81

1.10

ug/l

0.29

100

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

137

0.85

0.18

1.4

2.2

1.14

0.89

ug/l

0.35

125

Acute lymphadenitis

100

1.20

0.18

2.2

3.3

0.90

1.29

ug/l

0.51

Other obstructed labour

100

1.20

0.18

2.1

2.3

0.85

0.89

ug/l

0.04

Lung diseases due to external agents

129

1.16

0.17

1.1

2.1

0.75

1.30

ug/l

0.73

119

Pneumonitis due to solids and liquids

1.16

0.16

1.1

2.4

0.46

1.41

ug/l

—

Speech therapy

319

0.91

0.16

2.7

2.5

1.09

1.15

ug/l

0.10

299

Haemangioma and lymphangioma, any site

130

0.85

0.16

2.1

3.1

2.20

1.44

ug/l

0.26

122

Conotruncal defects

0.79

0.15

4.3

5.9

2.94

1.94

ug/l

—

Adenocarcinoma and papilloma adenocarcinoma of rectum

0.79

0.15

1.8

1.7

0.85

1.21

ug/l

—

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

149

1.14

0.15

2.5

2.3

1.14

0.94

ug/l

0.32

136

Coronary angioplasty

284

0.92

0.15

2.0

2.2

1.25

1.04

ug/l

0.30

268

Foreign body or object entering through skin

0.75

0.15

1.2

2.5

1.46

1.47

ug/l

—

Non-follicular lymphoma

1.21

0.15

2.3

1.9

1.30

1.33

ug/l

—

Haemangioma, any site

119

0.84

0.15

2.2

2.8

1.03

1.46

ug/l

—

109

Alzheimer disease, including avohilmo

128

1.13

0.15

1.4

1.7

1.19

1.25

ug/l

0.04

119

Caught, crushed, jammed or pinched in or between objects

1.11

0.15

1.8

3.1

2.24

1.46

ug/l

—

Hydronephrosis

121

1.16

0.15

1.9

2.3

1.13

1.17

ug/l

0.03

113

Hypertrophic disorders of skin

1.11

0.15

2.7

0.95

0.94

ug/l

—

Puerperal sepsis

140

1.14

0.15

1.6

2.1

0.90

1.14

ug/l

0.50

133

Other diseases of arteries and capillaries

1.10

0.15

2.1

2.0

1.14

1.12

ug/l

—

Haemangioma and lymphangioma, any site

129

0.85

0.14

2.1

3.1

2.20

1.42

ug/l

0.27

119

Antepartum haemorrhage, not elsewhere classified

139

0.86

0.14

1.9

2.3

0.76

1.23

ug/l

0.81

132

Anterior Iridocyclitis

264

0.91

0.14

3.1

2.4

0.80

1.16

ug/l

0.67

244

Fall on and from ladder

1.19

0.14

2.2

0.73

1.15

ug/l

—

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

0.81

0.13

3.6

2.0

0.99

1.03

ug/l

—

Other coagulation defects

1.17

0.13

1.0

2.6

1.75

1.09

ug/l

0.22

Myopia

209

1.10

0.13

1.7

2.8

0.67

1.37

ug/l

2.67

192

Nontraumatic intracranial haemmorrhage

161

1.12

0.12

1.9

2.3

1.97

1.14

ug/l

0.56

153

Non-follicular lymphoma, hilmo, excluding all cancers

1.18

0.12

2.3

2.1

1.30

1.29

ug/l

—

Crushed, pushed or stepped on by crowd or human stampede

133

1.13

0.12

1.7

3.3

1.67

1.53

ug/l

0.08

122

Overexertion and strenuous or repetitive movements

133

1.13

0.12

1.5

2.4

0.58

1.16

ug/l

1.34

120

Other interstitial pulmonary diseases

137

0.88

0.12

2.0

2.2

1.33

1.31

ug/l

0.01

129

Interstitial lung disease endpoints

137

0.88

0.12

2.0

2.2

1.33

1.31

ug/l

0.01

129

Interstitial lung disease

137

0.88

0.12

2.0

2.2

1.33

1.31

ug/l

0.01

129

ILD, hospital admissions

136

0.88

0.11

2.0

2.1

1.33

1.32

ug/l

0.01

128

Non-allergic asthma

134

1.12

0.10

3.2

3.7

1.72

1.55

ug/l

0.11

127

Follicular cysts of skin and subcutaneous tissue

229

0.92

0.10

2.0

2.2

0.86

1.12

ug/l

0.29

212

Malignant neoplasm of bronchus and lung

117

0.88

0.10

1.2

1.9

0.89

1.18

ug/l

0.48

109

COPD, hospital admissions 3, with asthma pneumonia sepsis

168

0.91

0.10

1.1

2.3

2.05

0.90

ug/l

0.97

159

Unspecified lump in breast

154

1.10

0.10

1.8

2.1

1.41

1.19

ug/l

0.17

144

Car occupant injured in noncollision transport accident

1.11

0.09

1.4

2.2

0.60

1.20

ug/l

—

Right ventricular outflow tract obstruction

1.09

0.09

4.4

6.3

3.44

2.08

ug/l

—

Overjet

1.14

0.09

4.1

5.4

1.84

1.82

ug/l

0.01

Haemangioma, any site

114

0.88

0.09

2.2

2.9

1.03

1.50

ug/l

—

107

Traumatic amputation of wrist and hand

1.06

0.09

1.0

2.2

0.59

1.28

ug/l

—

Duodenal ulcer

1.15

0.09

1.6

2.0

3.50

0.94

ug/l

—

Peripheral artery disease

298

0.95

0.09

1.3

2.0

2.52

0.94

ug/l

0.84

283

Artificial joint re-operation

1.11

0.09

2.2

1.9

0.78

1.47

ug/l

—

Atherosclerosis, excluding cerebral and coronary sclerosis

263

0.94

0.08

1.3

2.0

2.81

0.86

ug/l

0.96

250

Unspecified misadventure during surgical and medical care

1.07

0.08

7.0

2.3

0.59

1.27

ug/l

—

Pneumonia due to Streptococcus pneumoniae

1.05

0.08

2.0

2.4

2.35

1.37

ug/l

—

Atopic conjunctivitis

0.82

0.08

2.8

3.0

0.77

1.58

ug/l

—

Bicuspidal aortic valve syndrome

0.79

0.08

4.6

4.1

1.75

1.43

ug/l

—

Impacted maxillary molar

1.14

0.08

2.8

2.2

1.57

0.98

ug/l

—

Malignant neoplasm of urinary organs

1.14

0.08

1.4

2.2

1.76

1.28

ug/l

—

Pregnancy with abortive outcome

101

543

0.97

0.08

2.2

2.0

1.18

1.24

ug/l

0.13

524

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

0.85

0.07

1.0

1.9

1.62

1.12

ug/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

0.83

0.07

2.5

2.2

0.62

1.16

ug/l

—

Bronchitis, not specified as acute or chronic

1.12

0.07

1.0

2.2

1.35

1.10

ug/l

0.13

Polyhydramnios

0.80

0.07

1.0

2.0

0.22

1.37

ug/l

—

Carcinoma in situ of breast, intraductal

1.07

0.07

4.3

1.8

2.29

1.30

ug/l

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

0.84

0.07

1.7

1.9

0.90

1.13

ug/l

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

0.82

0.07

1.7

1.8

0.90

1.09

ug/l

—

Hypertrophy of breast

204

0.93

0.07

1.1

2.1

0.67

1.17

ug/l

1.65

193

Congenital malformations of the urinary system

118

1.10

0.07

4.3

4.1

2.10

1.73

ug/l

0.30

111

Wet age-related macular degeneration

0.88

0.06

1.4

1.6

1.11

1.31

ug/l

—

HSIL lesion of the cervix uteri, vagina or vulva

295

0.95

0.06

2.4

2.2

1.60

1.20

ug/l

0.37

282

Alzheimer’s disease (Late onset)

0.87

0.06

1.2

1.8

1.57

1.47

ug/l

—

Convergent concomitant strabismus

105

0.86

0.06

4.2

3.9

1.25

1.46

ug/l

—

Myocardial infarction, without ST-elevation

299

0.96

0.05

1.3

2.0

1.04

0.92

ug/l

0.15

281

Valvular operations

151

0.93

0.05

4.2

3.5

2.21

1.38

ug/l

0.59

142

Acute and subacute iridocyclitis

242

0.95

0.05

3.2

2.4

0.83

1.20

ug/l

0.68

224

Chronic periodontitis

140

1.07

0.04

3.9

1.9

1.34

0.93

ug/l

0.46

131

LSIL lesion of the cervix uteri

170

0.94

0.04

2.9

2.1

1.82

1.14

ug/l

0.45

161

Parkinson's disease, including avohilmo

109

0.92

0.04

3.2

1.9

1.64

1.18

ug/l

—

101

Glucosamine medication

373

1.03

0.03

1.6

2.2

1.11

1.05

ug/l

0.09

356

Superficial injury of wrist and hand

339

1.03

0.03

1.4

2.9

1.28

1.30

ug/l

0.02

319

Other respiratory diseases principally affecting the interstitium

159

0.94

0.03

2.0

2.4

1.78

1.33

ug/l

0.34

149

Ptosis of eyelid

1.08

0.02

2.6

2.3

1.90

1.30

ug/l

—

Abnormalities of forces of labour

163

1.04

0.01

1.9

2.2

1.29

1.04

ug/l

0.23

154

Parodontitis or/and operation codes

114

672

1.01

0.01

3.1

2.2

1.07

1.06

ug/l

0.02

109

623

Left ventricular outflow tract obstruction, narrow definition

106

0.94

0.01

4.7

4.4

4.66

1.66

ug/l

—

100

Parkinson's disease

106

0.94

0.01

3.2

1.8

1.64

1.21

ug/l

—

ILD, hospital admissions 1, main diag only

116

0.95

0.00

2.1

2.0

1.24

1.46

ug/l

0.16

108

Chalazion

126

0.95

0.00

2.5

1.02

1.16

ug/l

0.11

115

Seborrhoeic keratosis

197

1.02

0.00

2.1

2.0

2.07

0.88

ug/l

1.12

186

Chronic periodontitis, complicated

102

0.98

0.00

5.3

2.3

1.12

1.08

ug/l

—

Impetigo

1.04

0.00

4.1

4.6

1.23

1.64

ug/l

—

Contact with other sharp object(s)

101

0.99

0.00

2.0

2.7

1.55

1.34

ug/l

—

Use of donepezil

0.99

0.00

1.2

1.8

0.60

1.35

ug/l

—

Alzheimer’s disease, wide definition

101

0.99

0.00

1.2

1.9

1.25

1.36

ug/l

0.06

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

1.01

0.00

2.1

2.3

2.20

1.14

ug/l

—

Haemorrhagic and haematological disorders of fetus and newborn

144

0.99

0.00

6.2

5.8

3.71

2.05

ug/l

1.33

144

Allergic urticaria

131

0.99

0.00

2.8

3.2

1.16

1.46

ug/l

0.27

123

Alzheimer disease

117

1.03

0.00

1.4

1.8

1.42

1.32

ug/l

0.06

108

Bacterial, viral and other infectious agents

143

0.98

0.00

3.4

3.0

1.26

1.38

ug/l

0.07

130

Shigellosis

0.00

0.0

2.2

—

1.15

—

Gilbert syndrome

0.00

0.0

2.6

—

1.20

—

Other and unspecified hypertrophic disorders of skin

0.00

0.0

2.6

—

1.08

—

Presbyopia

0.95

0.00

2.3

2.2

0.71

0.93

ug/l

—

Acute hepatitis B

0.00

0.0

2.5

—

0.85

—

Occlusion and stenosis of arteries, not leading to stroke

0.00

0.0

1.9

—

1.55

—

Acute myringitis

0.00

0.0

3.9

—

2.41

—

Other specified and unspecified disorders of choroid

0.00

0.0

2.0

—

2.53

—

Osteosarcoma, excluding all cancers (controls excluding all cancers)

0.00

0.0

4.2

—

1.53

—

Abnormality of red blood cells

0.00

0.0

2.2

—

0.36

—

Amputation of toe

0.96

0.00

1.4

1.7

0.55

1.11

ug/l

—

Systemic disorders of connective tissue in diseases classified elsewhere (FG)

0.00

0.0

2.7

—

2.80

—

Haemolytic disease of fetus and newborn

0.00

0.0

5.2

—

2.98

—

Use of peginterferon beta-1a

0.00

0.0

3.2

—

1.29

—

Other and unspecified papulosquamous disorders

0.00

0.0

2.0

—

1.61

—

Peptic ulcer

0.00

0.0

2.8

—

1.70

—

Syndactyly

0.00

0.0

5.5

—

0.89

—

Pediculosis and phthiriasis

0.00

0.0

2.2

—

1.12

—

Exposure to excessive heat of man-made origin

0.00

0.0

3.4

—

1.28

—

Congenital malformation of vitreous humour

0.00

0.0

3.6

—

4.73

—

Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced

0.00

0.0

1.9

—

1.59

—

Ankylosis of joint

0.00

0.0

1.6

—

0.86

—

Stenosis and insufficiency of lacrimal passages

1.01

0.00

2.3

2.6

0.79

1.23

ug/l

—

Benign lipomatous neoplasm of other sites/unspecified

0.93

0.00

3.6

1.9

6.19

1.26

ug/l

—

Erectile dysfunction, exclusion

0.00

0.0

3.8

—

4.07

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

0.00

0.0

1.9

—

1.12

—

Dislocation of lens

0.00

0.0

3.9

—

1.38

—

Congenital lens malformations

0.00

0.0

3.9

—

1.02

—

LSIL lesion of the cervix uteri, vagina or vulva

200

1.00

0.00

2.5

2.1

1.73

1.15

ug/l

0.45

189

Anoxic brain damage

0.00

0.0

3.3

—

1.05

—

Parkinson's disease, strict definition

0.96

0.00

2.1

1.6

1.64

1.21

ug/l

—

ILD, hospital admission 2, with pulmonary infections

0.90

0.00

1.9

2.4

1.20

1.32

ug/l

—

Food allergy

0.00

0.0

4.0

—

2.94

—

Other and unspecified neuropathies

0.00

0.0

2.4

—

1.27

—

ILD, hospital admissions 3, with pneumonia sepsis

0.95

0.00

1.0

2.1

0.96

1.31

ug/l

—

Congenital retinoschisis

0.00

0.0

4.2

—

0.75

—

Traction detachment of retina

0.00

0.0

1.8

—

0.79

—

Peripheral artery operations in Hilmo

0.95

0.00

1.2

1.7

1.43

1.06

ug/l

—

Glaucoma secondary to drugs

0.00

0.0

3.5

—

1.96

—

Melanocytic naevi of lip

0.00

0.0

2.2

—

1.18

—

Other autoimmune haemolytic anaemias

0.00

0.0

2.9

—

1.96

—

Aphakia

0.00

0.0

2.4

—

1.40

—

Malignant neoplasm of kidney, except renal pelvis

0.90

0.00

1.6

2.3

2.29

1.33

ug/l

—

Qualitative platelet defects

0.00

0.0

5.0

—

1.23

—

Crushing injury of ankle and foot

0.00

0.0

2.0

—

1.42

—

Cleft lip and palate

0.00

0.0

5.8

—

1.28

—

Otorrhagia

0.00

0.0

3.9

—

0.81

—

Malignant neoplasm of parotid gland

0.00

0.0

1.8

—

1.45

—

Emphysema

0.91

0.00

1.0

2.2

3.64

1.11

ug/l

—

Labyrinthitis

0.00

0.0

3.3

—

3.96

—

Carcinoma in situ of skin of ear and external auricular canal

0.00

0.0

2.2

—

1.24

—

Benign neoplasm: Ribs, sternum and clavicle

0.00

0.0

3.0

—

1.98

—

Benign neoplasm: Pelvic bones, sacrum and coccyx

0.00

0.0

3.3

—

3.96

—

Carcinoma in situ of uteri, other/unspecified

0.00

0.0

2.0

—

1.72

—

Malignant immunoproliferative diseases

0.00

0.0

2.2

—

0.78

—

Malignant neoplasm of bone and articular cartilage of limbs

0.00

0.0

2.4

—

1.29

—

Benign neoplasm: Pelvic bones, sacrum and coccyx

0.00

0.0

3.3

—

3.98

—

Lung transplant status

0.00

0.0

3.1

—

1.63

—

Disorders of porphyrin and bilirubin metabolism

0.00

0.0

2.9

—

1.11

—

Lung transplantation

0.00

0.0

3.1

—

1.63

—

Discontinuity and dislocation of ear ossicles

0.00

0.0

3.4

—

3.79

—

Chronic myeloid leukaemia [CML], BCR/ABL-positive

0.00

0.0

2.2

—

1.12

—

Malignant neoplasm of hypopharynx, excluding all cancers (controls excluding all cancers)

0.00

0.0

3.8

—

1.45

—

Polyp of middle ear

0.00

0.0

5.9

—

1.26

—

Other specified/unspecified nutritional deficiencies

0.00

0.0

2.5

—

1.86

—

Melanocytic naevi of lip

0.00

0.0

2.3

—

1.42

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

0.87

0.00

2.5

2.4

0.62

1.19

ug/l

—

Female pelvic inflammatory disorders in diseases classified elsewhere

0.00

0.0

2.5

—

1.50

—

Foreign body granuloma of skin and subcutaneous tissue

0.00

0.0

2.7

—

4.49

—

Benign neoplasm: Brain, infratentorial

0.00

0.0

4.8

—

1.25

—

Acute gastritis

0.90

0.00

3.4

2.2

1.14

1.11

ug/l

—

Malignant neoplasm of other and unspecified parts of mouth

0.00

0.0

2.2

—

1.15

—

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

0.89

0.00

1.7

1.8

0.90

1.14

ug/l

—

Alcoholic cardiomyopathy

0.00

0.0

1.4

—

0.28

—

Malignant neoplasm of other and ill-defined digestive organs

0.00

0.0

1.0

—

1.52

—

Dissection of cerebral arteries, nonruptured

0.00

0.0

2.5

—

0.95

—

Hypertension, portal

0.00

0.0

1.0

—

0.98

—

Other nonthrombocytopenic purpura

0.00

0.0

2.3

—

1.38

—

Liposarcoma

0.00

0.0

2.2

—

1.12

—

Enteritis due to Yersinia enterocolitica

0.00

0.0

2.6

—

1.43

—

Cyst of iris, ciliary body and anterior chamber

0.00

0.0

3.0

—

5.25

—

Malignant neoplasm of head and neck

0.87

0.00

1.7

2.3

0.88

1.13

ug/l

—

ILD medications: acetylcysteine

0.00

0.0

3.4

—

2.34

—

Folate deficiency anaemia

0.00

0.0

1.0

—

1.75

—

Blindness or visual impairment, binocular

0.00

0.0

3.8

—

1.10

—

Malignant neoplasm of parotid gland, excluding all cancers (controls excluding all cancers)

0.00

0.0

3.0

—

1.09

—

Ependymoma

0.00

0.0

6.0

—

1.76

—

Malignant neoplasm of base of tongue

0.00

0.0

1.0

—

1.01

—

Eccrine sweat disorders

0.00

0.0

3.6

—

2.05

—

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

0.90

0.00

3.3

2.4

2.75

1.73

ug/l

—

Other inherited muscular atrophy

0.00

0.0

5.1

—

1.74

—

Ependymoma, excluding all cancers (controls excluding all cancers)

0.00

0.0

6.0

—

1.76

—

Benign neoplasm: Ribs, sternum and clavicle

0.00

0.0

3.0

—

1.99

—

Benign lipomatous neoplasm of other sites/unspecified

0.96

0.00

3.6

1.9

6.19

1.09

ug/l

—

0.00

0.0

2.0

—

1.75

—

Right side

0.00

0.0

2.2

—

0.66

—

Personal history of allergy to analgesic agent

0.00

0.0

2.0

—

1.52

—

Prophylactic surgery

0.00

0.0

2.0

—

1.73

—

Asymptomatic human immunodeficiency virus [HIV] infection status

0.00

0.0

1.0

—

0.80

—

Ankle and foot

0.00

0.0

2.2

—

1.47

—

Family history of mental and behavioural disorders

0.00

0.0

5.8

—

0.88

—

Sequelae of transport accidents

0.00

0.0

1.6

—

0.21

—

Arthropathy in hypersensitivity reactions classified elsewhere

0.00

0.0

3.4

—

3.77

—

Other and unspecified medical devices associated with adverse incidents

0.00

0.0

3.6

—

1.31

—

Occupant of pick-up truck or van injured in other and unspecified transport accidents

0.00

0.0

2.9

—

1.00

—

Pedal cyclist injured in collision with pedestrian or animal

0.00

0.0

1.3

—

1.43

—

Pedestrian injured in transport accident

0.97

0.00

1.4

2.5

2.38

1.11

ug/l

—

Exposure to other and unspecified forces of nature

0.00

0.0

4.9

—

0.94

—

Diving or jumping into water causing injury other than drowning or submersion

0.00

0.0

2.8

—

1.41

—

Contact with other specified venomous animals

0.00

0.0

2.6

—

1.77

—

Sequelae of burns, corrosions and frostbite

0.00

0.0

4.1

—

1.04

—

Generalized pustular psoriasis

0.00

0.0

3.2

—

1.66

—

Café au lait spots

0.00

0.0

5.1

—

4.76

—

Hair colour and hair shaft abnormalities

0.00

0.0

2.1

—

1.61

—

Effects of heat and light

0.00

0.0

2.6

—

2.15

—

Other and unspecified heterotropia

0.00

0.0

4.3

—

3.67

—

Toxic effect of organic solvents

0.00

0.0

1.4

—

0.45

—

Maze procedure for atrial fibrillation

0.00

0.0

2.2

—

1.12

—

Typhoid and paratyphoid fevers

0.00

0.0

1.0

—

1.77

—

Respiratory tuberculosis, clinically confirmed

0.00

0.0

3.1

—

1.23

—

Benign neoplasm: Endocrine pancreas

0.00

0.0

2.2

—

1.15

—

Pityriasis lichenoides chronica

0.00

0.0

3.6

—

1.40

—

Staphylococcal scalded skin syndrome

0.00

0.0

3.5

—

2.54

—

Migraine, unspecified, drug-induced

0.00

0.0

2.5

—

1.61

—

COPD-related respiratory insufficiency

1.01

0.00

1.0

2.0

3.14

0.96

ug/l

—

Hypertrophy of bone

0.00

0.0

2.6

—

0.50

—

Bacterial sepsis of newborn

1.02

0.00

7.8

6.3

1.42

2.15

ug/l

—

Osteogenesis imperfecta

0.00

0.0

6.7

—

1.68

—

Other congenital malformations of eye

0.00

0.0

4.6

—

3.01

—

Congenital glaucoma

0.00

0.0

4.0

—

2.71

—

Motor neuron disease

0.00

0.0

1.6

—

1.82

—

Disorders of male genital organs in diseases classified elsewhere

0.00

0.0

1.0

—

0.26

—

Congenital malformations of aortic and mitral valves

1.01

0.00

5.1

4.3

3.29

1.62

ug/l

—

Neonatal aspiration syndromes

0.00

0.0

5.0

—

1.11

—

Infections specific to the perinatal period

0.96

0.00

7.4

6.0

2.01

2.07

ug/l

—

Labour and delivery complicated by umbilical cord complications

0.87

0.00

1.2

2.0

1.14

0.91

ug/l

—

Unspecified renal colic

0.00

0.0

1.8

—

1.80

—

0.00

-0.00

0.0

1.9

—

1.42

—

Meningococcal infection

0.00

-0.00

0.0

2.2

—

1.89

—

Digeorge syndrome

0.00

-0.00

0.0

6.2

—

4.81

—

Other congenital malformations of respiratory system

0.00

-0.00

0.0

4.6

—

4.17

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Somatotropin [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS